<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Internet Res</journal-id><journal-id journal-id-type="iso-abbrev">J Med Internet Res</journal-id><journal-id journal-id-type="publisher-id">JMIR</journal-id><journal-title-group><journal-title>Journal of Medical Internet Research</journal-title></journal-title-group><issn pub-type="ppub">1439-4456</issn><issn pub-type="epub">1438-8871</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40328443</article-id><article-id pub-id-type="pmc">PMC12093078</article-id><article-id pub-id-type="publisher-id">v27i1e70133</article-id><article-id pub-id-type="doi">10.2196/70133</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group><subj-group subj-group-type="article-type"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Identifying Medication Review Topics to Be Documented in a Structured Form in Electronic Health Record Systems: Delphi Consensus Survey</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Sarvestan</surname><given-names>Javad</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Myrka</surname><given-names>Anne</given-names></name></contrib><contrib contrib-type="reviewer"><name><surname>Wreyford</surname><given-names>Leon</given-names></name></contrib></contrib-group><contrib-group><contrib id="contrib1" contrib-type="author" corresp="yes"><name><surname>Lindholm</surname><given-names>Tanja</given-names></name><degrees>MSc</degrees><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-3474-2207</contrib-id><xref rid="aff1" ref-type="aff">1</xref><address><institution>Clinical Pharmacy Group, Division of Pharmacology and Pharmacotherapy</institution><institution>Faculty of Pharmacy</institution><institution>University of Helsinki</institution><addr-line>Viikinkaari 5 E</addr-line><addr-line>P.O. Box 56</addr-line><addr-line>Helsinki, 00014 University of Helsinki</addr-line><country>Finland</country><phone>358 2941911</phone><email>tanja.p.lindholm@helsinki.fi</email></address></contrib><contrib id="contrib2" contrib-type="author"><name><surname>Lias</surname><given-names>Noora</given-names></name><degrees>MSc</degrees><xref rid="aff1" ref-type="aff">1</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-5356-3969</contrib-id></contrib><contrib id="contrib3" contrib-type="author"><name><surname>Kvarnstr&#x000f6;m</surname><given-names>Kirsi</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3136-5972</contrib-id></contrib><contrib id="contrib4" contrib-type="author"><name><surname>Holmstr&#x000f6;m</surname><given-names>Anna-Riia</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">1</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3908-5430</contrib-id></contrib><contrib id="contrib5" contrib-type="author"><name><surname>Toivo</surname><given-names>Terhi</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff4" ref-type="aff">4</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8357-2714</contrib-id></contrib><contrib id="contrib6" contrib-type="author"><name><surname>Uusitalo</surname><given-names>Marjo</given-names></name><degrees>MSc</degrees><xref rid="aff5" ref-type="aff">5</xref><xref rid="aff6" ref-type="aff">6</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-8878-1247</contrib-id></contrib><contrib id="contrib7" contrib-type="author"><name><surname>Nurmi</surname><given-names>Harri</given-names></name><degrees>MSc</degrees><xref rid="aff7" ref-type="aff">7</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-5401-0307</contrib-id></contrib><contrib id="contrib8" contrib-type="author"><name><surname>Airaksinen</surname><given-names>Marja</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">1</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6077-5671</contrib-id></contrib></contrib-group><aff id="aff1">
<label>1</label>
<institution>Clinical Pharmacy Group, Division of Pharmacology and Pharmacotherapy</institution>
<institution>Faculty of Pharmacy</institution>
<institution>University of Helsinki</institution>
<addr-line>Helsinki</addr-line>
<country>Finland</country>
</aff><aff id="aff2">
<label>2</label>
<institution>HUS Pharmacy</institution>
<institution>Helsinki University Hospital</institution>
<addr-line>Helsinki</addr-line>
<country>Finland</country>
</aff><aff id="aff3">
<label>3</label>
<institution>HUS Internal Medicine and Rehabilitation</institution>
<institution>Helsinki University Hospital</institution>
<addr-line>Helsinki</addr-line>
<country>Finland</country>
</aff><aff id="aff4">
<label>4</label>
<institution>Hospital Pharmacy, Wellbeing Services County of Pirkanmaa</institution>
<institution>Tampere University Hospital</institution>
<addr-line>Tampere</addr-line>
<country>Finland</country>
</aff><aff id="aff5">
<label>5</label>
<institution>Innovation and Development Unit</institution>
<institution>Istekki Ltd</institution>
<addr-line>Kuopio</addr-line>
<country>Finland</country>
</aff><aff id="aff6">
<label>6</label>
<institution>Faculty of Medicine and Health Technology</institution>
<institution>Tampere University</institution>
<addr-line>Tampere</addr-line>
<country>Finland</country>
</aff><aff id="aff7">
<label>7</label>
<institution>Finnish Medicines Agency Fimea</institution>
<addr-line>Helsinki</addr-line>
<country>Finland</country>
</aff><author-notes><corresp>Corresponding Author: Tanja Lindholm <email>tanja.p.lindholm@helsinki.fi</email></corresp></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>6</day><month>5</month><year>2025</year></pub-date><volume>27</volume><elocation-id>e70133</elocation-id><history><date date-type="received"><day>19</day><month>12</month><year>2024</year></date><date date-type="rev-request"><day>24</day><month>2</month><year>2025</year></date><date date-type="rev-recd"><day>17</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>3</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9;Tanja Lindholm, Noora Lias, Kirsi Kvarnstr&#x000f6;m, Anna-Riia Holmstr&#x000f6;m, Terhi Toivo, Marjo Uusitalo, Harri Nurmi, Marja Airaksinen. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 06.05.2025.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link xlink:href="https://creativecommons.org/licenses/by/4.0/" ext-link-type="uri">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on <ext-link xlink:href="https://www.jmir.org/" ext-link-type="uri">https://www.jmir.org/</ext-link>, as well as this copyright and license information must be included.</license-p></license></permissions><self-uri xlink:href="https://www.jmir.org/2025/1/e70133"/><abstract><sec sec-type="background"><title>Background</title><p>Poor data transfer and interoperability between electronic health record (EHR) systems has been a challenge hindering availability and usability of patient information in clinical practice and evidence-based decision-making. To improve data transfer and interoperability, patient information should be documented in a structured format. This also applies to medication-related patient information and results of the interventions, such as medication reviews (MRs), to individually optimize medication regimens, especially in older adults.</p></sec><sec sec-type="objective"><title>Objective</title><p>This study aimed to identify what information obtained from MRs should be documented in a structured form in EHRs at a national and organizational level.</p></sec><sec sec-type="methods"><title>Methods</title><p>The study was conducted as a 3-round Delphi consensus survey in 2020. The electronic survey was based on a comprehensive inventory of international and national MR procedures in various settings. Expert panelists (N=41) independently assessed which topics should be documented in a structured form in EHRs. The interprofessional panel (N=41) consisted of 12 physicians, 13 pharmacists, 10 nurses, and 6 information management professionals (participation rate 66%-76% in rounds 1-3; consensus limit set at 80%). The responses were analyzed quantitatively and qualitatively.</p></sec><sec sec-type="results"><title>Results</title><p>Consensus was reached on 97.3% (108/111) of predetermined topics to be documented in a structured form in EHRs. Of these, 39 concerned the MR process, 25 related to potentially drug-induced symptoms, 11 related to burden of risks for adverse drug effects, 12 related to laboratory tests and other test results, 12 related to medication adherence, and 9 related to the use of intoxicants. The patient&#x02019;s blood pressure (mean 4.85, SD 0.53; on a Likert scale 1-5), kidney function (mean 4.81, SD 0.56), and risk of bleeding (mean 4.81, SD 0.56) were ranked as the 3 most important topics to be documented in a structured form. The panel reached a consensus that the information obtained from MRs should be made available to all health care professionals in the national digital repository for patient data and to patients to some extent.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>The interprofessional expert panel strongly agreed on the results of the MRs that should be documented in a structured form in EHRs and made available to both health professionals involved in care teams and patients themselves.</p></sec></abstract><kwd-group><kwd>medication review</kwd><kwd>structured documentation</kwd><kwd>information management</kwd><kwd>electronic health record</kwd><kwd>patient information</kwd><kwd>medication information</kwd><kwd>medical informatics</kwd></kwd-group></article-meta></front><body><sec sec-type="introduction"><title>Introduction</title><sec><title>Background</title><p>Health care across the world is undergoing digitalization with the goal of well-integrated systems leading to improved work efficiency and patient safety [<xref rid="ref1" ref-type="bibr">1</xref>,<xref rid="ref2" ref-type="bibr">2</xref>]. However, the transition phase toward well-functioning digital systems is characterized by fragmented, immature medical records that have become a major challenge and patient safety risk in various health care functions and settings [<xref rid="ref3" ref-type="bibr">3</xref>-<xref rid="ref9" ref-type="bibr">9</xref>]. The key issue is that patient information is collected and documented in numerous local and national data systems that do not communicate or enable data access or data transfer between social and health care organizations or even within an organization. This siloed, fragmented information is difficult to share, blurring the overall picture of the treatment and making it difficult for any care team member to take full responsibility for the patient&#x02019;s care coordination [<xref rid="ref4" ref-type="bibr">4</xref>,<xref rid="ref10" ref-type="bibr">10</xref>]. Thus, standardized terminology and operating models are needed for documenting patient information in a structured format to enable data transfer and interoperability between health care units, regardless of the organization or electronic health record (EHR) system [<xref rid="ref11" ref-type="bibr">11</xref>-<xref rid="ref17" ref-type="bibr">17</xref>]. This would also enable the secondary use of patient data when estimating the effectiveness of care or future need for health care services.</p><p>The same kind of challenges with fragmented patient information apply to documenting patient information on medication regimens to EHRs which has led to shortcomings and safety risks in managing and obtaining up-to-date medication information [<xref rid="ref18" ref-type="bibr">18</xref>]. In medication risk management, medication reviews (MRs), that is, a structured evaluation of a patient&#x02019;s medication regimen with the aim of optimizing medicines use and improving health outcomes, are an important strategy for identifying and solving medication-related risks and problems [<xref rid="ref19" ref-type="bibr">19</xref>-<xref rid="ref23" ref-type="bibr">23</xref>]. Traditionally, MRs have been a physician&#x02019;s duty, but practices where other care team members, including pharmacists, contribute to MRs have become more common globally [<xref rid="ref24" ref-type="bibr">24</xref>-<xref rid="ref26" ref-type="bibr">26</xref>]. Collaborative MRs have increased the need for a common electronic platform, where MR information can be documented in such a way that it is up to date and available to all health care professionals involved in the medication use process [<xref rid="ref1" ref-type="bibr">1</xref>,<xref rid="ref27" ref-type="bibr">27</xref>,<xref rid="ref28" ref-type="bibr">28</xref>].</p></sec><sec><title>Objective</title><p>Structured documentation offers a possible solution to these issues [<xref rid="ref12" ref-type="bibr">12</xref>-<xref rid="ref14" ref-type="bibr">14</xref>,<xref rid="ref16" ref-type="bibr">16</xref>]. To implement structured documentation of medication information, an understanding of what MR information should be available in a structured form is needed. However, no previous studies were found that defined MR information necessary to be documented in a structured form. Therefore, this study aimed at identifying what patient information obtained from MRs should be documented in a structured form in EHRs at a national and organizational level.</p></sec></sec><sec sec-type="methods"><title>Methods</title><sec><title>Context</title><p>The Finnish health care system serves a population of 5.5 million inhabitants and is mainly based on public health care, complemented by private and occupational health care [<xref rid="ref29" ref-type="bibr">29</xref>]. The services are divided into primary and specialized health care services. The social and health care system is undergoing a major reform that officially started at the beginning of 2023 after a long preparatory phase [<xref rid="ref30" ref-type="bibr">30</xref>]. Since then, 21 well-being services counties, the City of Helsinki, and the HUS Group (the joint authority for Helsinki and Uusimaa responsible for organizing specialized health care in the Uusimaa region) have been responsible for organizing public social and health care services. The key objective of the reform is improving the availability and accessibility of social and health services, for example, through digitalization of care pathways and patient information. The reform also concerns structures and processes needed for ensuring rational pharmacotherapy as part of patient care [<xref rid="ref29" ref-type="bibr">29</xref>,<xref rid="ref31" ref-type="bibr">31</xref>]. Availability of up-to-date electronic medication information and information transfer have been prioritized as the most important issues to be developed in this respect [<xref rid="ref29" ref-type="bibr">29</xref>-<xref rid="ref32" ref-type="bibr">32</xref>].</p><p>Use of information technology in prescribing medicines, processing prescriptions, and making medicines information available has been a routine practice in Finland since the 1980s when the first technology-based solutions were launched and nationally implemented [<xref rid="ref33" ref-type="bibr">33</xref>-<xref rid="ref35" ref-type="bibr">35</xref>]. The deployment of the national digital repository for electronic patient data Kanta since 2010 is one of the most prominent milestones toward electronic patient and medication information management in a closed-loop manner [<xref rid="ref29" ref-type="bibr">29</xref>,<xref rid="ref33" ref-type="bibr">33</xref>,<xref rid="ref36" ref-type="bibr">36</xref>,<xref rid="ref37" ref-type="bibr">37</xref>]. It enables electronic prescribing and centralized archiving of electronic patient data and data transfer between different health care providers regardless of local EHR. Electronic prescribing became mandatory by law in 2017 [<xref rid="ref38" ref-type="bibr">38</xref>]. The Finnish Institute for Welfare and Health (THL) is nationally responsible for the definition, distribution, and harmonization of the structures of patient information [<xref rid="ref39" ref-type="bibr">39</xref>,<xref rid="ref40" ref-type="bibr">40</xref>]. Thus, it has played a crucial role in the development and harmonization of medication information management in EHRs by describing the target state of medication information documentation which has emphasized the importance of structured documentation. Structured documentation is also increasingly adopted in Kanta and EHRs to address shortcomings regarding data transfer and interoperability as patient and medication information is still stored in hundreds of separate systems [<xref rid="ref39" ref-type="bibr">39</xref>-<xref rid="ref41" ref-type="bibr">41</xref>].</p><p>Among the driving forces for the ongoing health and social services reform in Finland are the challenges in meeting the service needs of one of the fastest aging populations in the world [<xref rid="ref29" ref-type="bibr">29</xref>,<xref rid="ref42" ref-type="bibr">42</xref>]. Aging has increased multimorbidity and complexity of medication treatments, also increasing medication-related risks and problems [<xref rid="ref4" ref-type="bibr">4</xref>,<xref rid="ref20" ref-type="bibr">20</xref>,<xref rid="ref43" ref-type="bibr">43</xref>-<xref rid="ref48" ref-type="bibr">48</xref>]. Therefore, collaborative MR practices have been developed in Finland since 2005 as a measure to optimize medication treatments individually and to avoid preventable risks and harms [<xref rid="ref20" ref-type="bibr">20</xref>,<xref rid="ref23" ref-type="bibr">23</xref>,<xref rid="ref48" ref-type="bibr">48</xref>-<xref rid="ref50" ref-type="bibr">50</xref>]. As a result, the medication management process has become increasingly interprofessional, extending the need to share medication-related information from electronic prescriptions to follow-up information on the implementation of the medication regimen.</p></sec><sec><title>The Delphi Consensus Method</title><sec><title>Overview</title><p>This study applied the Delphi consensus method, which is a qualitative survey-based method gathering views of experts with the aim of reaching consensus on the studied topic [<xref rid="ref51" ref-type="bibr">51</xref>-<xref rid="ref54" ref-type="bibr">54</xref>]. The expertise and anonymity of the expert panelists, the iteration of research arguments, and the feedback given to the experts on the results of the previous round are the method&#x02019;s key characteristics. The method has been widely used in health services research for developing treatment recommendations, quality standards and indicators, risk-management tools, and integrating health service systems [<xref rid="ref21" ref-type="bibr">21</xref>,<xref rid="ref55" ref-type="bibr">55</xref>-<xref rid="ref65" ref-type="bibr">65</xref>]. For this study, 3 Delphi rounds were carried out as electronic surveys in September to December 2020 using the eDelphi software developed by Metodix Ltd [<xref rid="ref66" ref-type="bibr">66</xref>]. The process was led by an 8-member research group consisting of experienced pharmacy professionals familiar with health care information systems, EHR development, IT architecture, and collaborative MRs in various operating environments, having also expertise in Delphi research methodology. The study is reported in alignment with the guidance on Conducting and REporting DElphi Studies (CREDES; <xref rid="app1" ref-type="supplementary-material">Multimedia Appendix 1</xref>).</p></sec><sec><title>Expert Panel</title><p>The interprofessional expert panel consisted of the following 41 members recruited by the research group from different parts of Finland: 12 physicians, 13 pharmacists, 10 nurses, and 6 information management professionals. The recruitment had characteristics of snowball sampling, as the selected experts were invited to recommend other professionals as potential members of the expert panel. The primary criterion for the experts was MR expertise. The recruited experts needed to have experience of using patient and medication information in practice, enter MR information into data systems, and understand the possibilities and limitations of structured documentation in EHRs.</p><p>Another primary target group of the study were information management professionals (n=6) from different national authorities who had experience in developing EHR systems or other national health information systems. Many of them also had been working as health care professionals, and therefore, understood the importance of structured documentation in EHR systems, bringing invaluable insights to this study. The physicians (n=12) came from various health care organizations and specialties (eg, geriatrics, acute medicine, and oncology), national authorities, and organizations developing EHR systems. The pharmacists (n=13) came from various health care organizations, national authorities, universities, community and hospital pharmacies, and organizations specialized in developing EHR systems. Similarly, the nurses (n=10) were from different areas of health care, working in emergency and geriatric care, some having special expertise in patient safety as well as developing EHRs and closed-loop medication processes.</p><p>EHR vendors were excluded from this study as the researchers did not want commercial interests or conflict of interests influencing the results. Furthermore, this study was primarily aimed at representing the mindset of public-sector health care professionals who conduct MRs because public health care is the mainstay in Finland.</p></sec><sec><title>Identifying MR Topics for the First Delphi Round</title><p>MR topics for the first electronic Delphi round survey were identified by comprehensively reviewing literature on national and international MR definitions, procedures, practices, and inventories in various settings [<xref rid="ref20" ref-type="bibr">20</xref>,<xref rid="ref22" ref-type="bibr">22</xref>,<xref rid="ref24" ref-type="bibr">24</xref>-<xref rid="ref26" ref-type="bibr">26</xref>,<xref rid="ref48" ref-type="bibr">48</xref>,<xref rid="ref50" ref-type="bibr">50</xref>,<xref rid="ref67" ref-type="bibr">67</xref>-<xref rid="ref80" ref-type="bibr">80</xref>] (<xref rid="figure1" ref-type="fig">Figure 1</xref>). In addition, internationally recognized and most widely used criteria of potentially inappropriate medications for older adults and drug-related problems (DRPs) were used [<xref rid="ref55" ref-type="bibr">55</xref>,<xref rid="ref56" ref-type="bibr">56</xref>,<xref rid="ref81" ref-type="bibr">81</xref>-<xref rid="ref86" ref-type="bibr">86</xref>]. A validated tool for assessing risks for DRPs to be used by practical nurses caring for home-dwelling older adults, and a validated checklist for medication-related risk factors (L&#x000e4;&#x000e4;kehoidon onnistumisen tarkistuslista LOTTA checklist) to be self-assessed by older adults were also used [<xref rid="ref21" ref-type="bibr">21</xref>,<xref rid="ref49" ref-type="bibr">49</xref>,<xref rid="ref87" ref-type="bibr">87</xref>]. The identified MR topics were inductively divided into six categories: (1) MR process topics, (2) potentially drug-induced symptoms, (3) the burden of risks for adverse drug effects, (4) laboratory tests and other test results, (5) medication adherence, and (6) the use of intoxicants.</p><p>The first Delphi round&#x02019;s survey instrument was piloted by 18 experts other than panel members before the actual round to ensure the face and content validity and usability of the survey [<xref rid="ref88" ref-type="bibr">88</xref>]. The results of the pilot were analyzed and compared by the 2 main researchers (TL and NL) who then presented their findings to the research group. On the basis of the pilot, a few minor changes were made to the survey. Examples of liver function tests (ALAT, ASAT, and GT), examples of electrolytes (potassium and sodium), and the orthostatic test were added to laboratory tests and other test results. In addition, the wording of 1 item was modified (&#x0201c;The medicine user is afraid of possible adverse effects&#x0201d; was modified into &#x0201c;The medicine user expresses concern about possible adverse effects&#x0201d;).</p><p>The panelists could choose from the following structured answer options when assessing each of the presented topics during rounds 1 and 2: (1) &#x0201c;Yes, as presented&#x0201d;; (2) &#x0201c;Yes, but modified&#x0201d;; (3) &#x0201c;Not at all&#x0201d;; and (4) &#x0201c;Cannot say.&#x0201d; In each round, the panelists were asked to justify their answer in an open comment field if they chose to answer with option 3, &#x0201c;Not at all.&#x0201d; The panelists were asked to comment and suggest changes if the presented topic was suitable but after modifications. The panelists were encouraged to provide comments and justifications for their choices in the open comment fields and to suggest new additional potentially missing topics.</p><fig position="float" id="figure1"><label>Figure 1</label><caption><p>The study outline aimed at identifying medication review topics to be documented in a structured form in electronic health records.</p></caption><graphic xlink:href="jmir_v27i1e70133_fig1" position="float"/></fig></sec><sec><title>Delphi Round 1</title><p>During the first Delphi round, the panelists were asked to assess which MR-related patient information and other patient data (N=104) should be documented in a structured form in EHRs (<xref rid="figure2" ref-type="fig">Figure 2</xref>).</p><fig position="float" id="figure2"><label>Figure 2</label><caption><p>The distribution of medication review topic input by category for Delphi rounds 1 to 3. Rating the importance of the topics in the third Delphi round was conducted on a Likert scale 1 to 5 (5: important topic, 4: moderately important topic, 3: cannot say, 2: moderately unimportant, and 1: unimportant topic). EHR: electronic health record.</p></caption><graphic xlink:href="jmir_v27i1e70133_fig2" position="float"/></fig></sec><sec><title>Delphi Round 2</title><p>The second Delphi round consisted of the topics for which consensus was not reached during the first round. New topics suggested by the panelists during the first round were also added. Thus, a total of 45-MR topics were presented to the expert panelists during the second round (<xref rid="figure2" ref-type="fig">Figure 2</xref>). In addition, the expert panelists were asked to assess if MR-related information should be available in the national Kanta and MyKanta services. MyKanta is a web-based part of Kanta through which citizens can access their health information, patient data, prescriptions, and laboratory test results documented by health care providers [<xref rid="ref89" ref-type="bibr">89</xref>,<xref rid="ref90" ref-type="bibr">90</xref>].</p></sec><sec><title>Delphi Round 3</title><p>During the third round, the expert panelists were asked to rate the importance of each of the topics for which consensus was reached during the first and second rounds (N=108) on a Likert scale from 1 to 5 (<xref rid="figure2" ref-type="fig">Figure 2</xref>). The importance of prioritization was emphasized, as not all topics can be structured at the same time. In addition, the expert panelists were asked to take the context into consideration, as not every topic is appropriate for every patient.</p></sec><sec><title>Data Analysis</title><p>The responses from each Delphi round were analyzed with Microsoft Excel by the 2 main researchers (TL and NL) who then compared their findings. The results were presented to and discussed with the whole research group that also resolved possible disagreements and approved the survey instrument to be sent for the next Delphi round. The results were reported using descriptive analysis with the main parameters being frequencies and percentages with SDs. Responses to the open-ended questions were analyzed qualitatively using inductive content analysis to modify the topics for the next round [<xref rid="ref91" ref-type="bibr">91</xref>]. The consensus limit was set at 80% [<xref rid="ref54" ref-type="bibr">54</xref>,<xref rid="ref92" ref-type="bibr">92</xref>].</p></sec></sec><sec><title>Ethical Considerations</title><p>The study was conducted in accordance with the national guidelines for responsible conduct of research and procedures for handling allegations of misconduct in Finland by the Finnish Advisory Board on Research Integrity [<xref rid="ref93" ref-type="bibr">93</xref>]. The ethical principles of research with human participants and ethical review in the human sciences in Finland by the Finnish National Board on Research Integrity were followed [<xref rid="ref94" ref-type="bibr">94</xref>]. According to the guidelines, a review by the research ethics committee and their approval were not required for this study. Participating in the expert panel was voluntary, and written informed consent was received from all expert panelists. The expert panelists were aware that their responses would be treated anonymously and used for research purposes only. The research material is stored in accordance with current regulations, considering the General Data Protection Regulation of the European Union [<xref rid="ref95" ref-type="bibr">95</xref>].</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Participation Rates</title><p>The results of the study consist of the MR topics for which consensus was reached during the 3 Delphi rounds. The response rates for all respondents (N=41) were 66% to 76% during all 3 Delphi rounds (<xref rid="table1" ref-type="table">Table 1</xref>).</p><table-wrap position="float" id="table1"><label>Table 1</label><caption><p>The number of experts participating in the 3 Delphi rounds, the number of respondents, and response rates in each round. Response rates varied depending on the question as answering all questions was not mandatory.</p></caption><table frame="hsides" rules="groups" width="1000" cellpadding="5" cellspacing="0" border="1"><col width="30" span="1"/><col width="370" span="1"/><col width="200" span="1"/><col width="200" span="1"/><col width="200" span="1"/><thead><tr valign="top"><td colspan="2" rowspan="1">Expert panel</td><td rowspan="1" colspan="1">Round 1</td><td rowspan="1" colspan="1">Round 2</td><td rowspan="1" colspan="1">Round 3</td></tr></thead><tbody><tr valign="top"><td colspan="5" rowspan="1">
<bold>Experts participating in the study, n</bold>
</td></tr><tr valign="top"><td rowspan="1" colspan="1">
<break/>
</td><td rowspan="1" colspan="1">All professional groups</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">41</td></tr><tr valign="top"><td rowspan="1" colspan="1">
<break/>
</td><td rowspan="1" colspan="1">Physicians</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">12</td></tr><tr valign="top"><td rowspan="1" colspan="1">
<break/>
</td><td rowspan="1" colspan="1">Pharmacists</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">13</td></tr><tr valign="top"><td rowspan="1" colspan="1">
<break/>
</td><td rowspan="1" colspan="1">Nurses</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">10</td></tr><tr valign="top"><td rowspan="1" colspan="1">
<break/>
</td><td rowspan="1" colspan="1">Information management professionals</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">6</td></tr><tr valign="top"><td colspan="5" rowspan="1">
<bold>Experts who answered in each round, n (%)</bold>
</td></tr><tr valign="top"><td rowspan="1" colspan="1">
<break/>
</td><td rowspan="1" colspan="1">All professional groups</td><td rowspan="1" colspan="1">30-31 (73-76)</td><td rowspan="1" colspan="1">27-29 (66-71)</td><td rowspan="1" colspan="1">27-28 (66-68)</td></tr><tr valign="top"><td rowspan="1" colspan="1">
<break/>
</td><td rowspan="1" colspan="1">Physicians</td><td rowspan="1" colspan="1">8 (67)</td><td rowspan="1" colspan="1">8 (67)</td><td rowspan="1" colspan="1">6 (50)</td></tr><tr valign="top"><td rowspan="1" colspan="1">
<break/>
</td><td rowspan="1" colspan="1">Pharmacists</td><td rowspan="1" colspan="1">13 (100)</td><td rowspan="1" colspan="1">12 (92)</td><td rowspan="1" colspan="1">12 (92)</td></tr><tr valign="top"><td rowspan="1" colspan="1">
<break/>
</td><td rowspan="1" colspan="1">Nurses</td><td rowspan="1" colspan="1">5-6 (50-60)</td><td rowspan="1" colspan="1">5 (50)</td><td rowspan="1" colspan="1">6 (60)</td></tr><tr valign="top"><td rowspan="1" colspan="1">
<break/>
</td><td rowspan="1" colspan="1">Information management professionals</td><td rowspan="1" colspan="1">4 (67)</td><td rowspan="1" colspan="1">2-4 (33-67)</td><td rowspan="1" colspan="1">3-4 (50-67)</td></tr></tbody></table></table-wrap></sec><sec><title>Consensus</title><p>Of the 111 topics, the expert panelists reached consensus on 108 (97.3%) topics during the 3 Delphi rounds as shown in <xref rid="figure3" ref-type="fig">Figure 3</xref> and <xref rid="app2" ref-type="supplementary-material">Table S1 in Multimedia Appendix 2</xref>. During the first Delphi round, consensus was reached for 67 of 104 (64%) MR topics that the expert panelists assessed should be documented in a structured form in EHRs. Topics (n=37) for which consensus was not reached during the first Delphi round were modified and, if necessary, clarified based on the expert panelists&#x02019; comments. For consensus to be reached during the first Delphi round, it was determined based on the number of respondents (n=30-31) that 24 (77%) of the experts had to accept the presented MR topic. The expert panelists reached a consensus on 42 out of 45 (93%)-MR topics during the second Delphi round (<xref rid="figure3" ref-type="fig">Figure 3</xref>; <xref rid="app2" ref-type="supplementary-material">Table S1 in Multimedia Appendix 2</xref>). Depending on the varying response rate (n=27-29) for each question during the second Delphi round, it was determined that 21 to 22 (77%) of the experts had to accept the presented topic for consensus to be reached. A clear consensus was also reached regarding that the MR-related information should be available in the national Kanta (29/29, 100%) and MyKanta services (25/29, 86%).</p><fig position="float" id="figure3"><label>Figure 3</label><caption><p>A summary of the results of the Delphi rounds 1 to 3. One of the medication review process topics (duration of drug treatment) was not prioritized in the third round due to technical issues.</p></caption><graphic xlink:href="jmir_v27i1e70133_fig3" position="float"/></fig></sec><sec><title>Importance</title><p>During the final third round, the expert panelists rated the structured documentation of most of the topics for which consensus had been reached during the previous rounds as important or somewhat important with 92 of the 108 topics (85%) reaching a mean of at least 4.0 (<xref rid="app2" ref-type="supplementary-material">Table S1 in Multimedia Appendix 2</xref>; <xref rid="table2" ref-type="table">Table 2</xref>). The 10 most important topics according to the experts are presented in <xref rid="table2" ref-type="table">Table 2</xref>.</p><table-wrap position="float" id="table2"><label>Table 2</label><caption><p>The 10 most important medication review items that should be documented in a structured form in the electronic health records. The items are presented in a descending order of the mean ratings and SD for each item as established in the third Delphi round on a Likert scale 1 to 5 (5: important topic, 4: moderately important topic, 3: cannot say, 2: moderately unimportant topic and 1: unimportant topic).</p></caption><table frame="hsides" rules="groups" width="1000" cellpadding="5" cellspacing="0" border="1"><col width="500" span="1"/><col width="500" span="1"/><thead><tr valign="top"><td rowspan="1" colspan="1">Medication review item</td><td rowspan="1" colspan="1">Ratings, mean (SD)</td></tr></thead><tbody><tr valign="top"><td rowspan="1" colspan="1">Blood pressure</td><td rowspan="1" colspan="1">4.85 (0.53)</td></tr><tr valign="top"><td rowspan="1" colspan="1">Kidney function tests</td><td rowspan="1" colspan="1">4.81 (0.56)</td></tr><tr valign="top"><td rowspan="1" colspan="1">Risk of bleeding</td><td rowspan="1" colspan="1">4.81 (0.56)</td></tr><tr valign="top"><td rowspan="1" colspan="1">Date of medication reconciliation</td><td rowspan="1" colspan="1">4.78 (0.51)</td></tr><tr valign="top"><td rowspan="1" colspan="1">Drug-drug interactions</td><td rowspan="1" colspan="1">4.78 (0.51)</td></tr><tr valign="top"><td rowspan="1" colspan="1">Inexplicable bruises, nose bleeds, or dark stools</td><td rowspan="1" colspan="1">4.78 (0.58)</td></tr><tr valign="top"><td rowspan="1" colspan="1">Blood glucose level</td><td rowspan="1" colspan="1">4.78 (0.58)</td></tr><tr valign="top"><td rowspan="1" colspan="1">International normalized ratio</td><td rowspan="1" colspan="1">4.78 (0.58)</td></tr><tr valign="top"><td rowspan="1" colspan="1">Sedative burden</td><td rowspan="1" colspan="1">4.78 (0.58)</td></tr><tr valign="top"><td rowspan="1" colspan="1">Renal toxicity burden</td><td rowspan="1" colspan="1">4.78 (0.58)</td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="discussion"><title>Discussion</title><sec><title>Principal Findings</title><p>A large and committed interprofessional expert panel was obtained for this Delphi study, which enabled the identification and prioritization of MR topics that should be documented in a structured form in EHRs. To our knowledge, this is the first reported study aimed at systematically identifying these topics at the national level. Interprofessional studies involving professionals participating in patient care are essential when developing EHR systems and defining their contents. This approach ensures the views of different professional groups are integrated, enhancing the usability and compatibility of systems. The Delphi method proved to be suitable for this purpose. The structured documentation of MR topics in EHRs was perceived as important or somewhat important in most of the presented topics, including basic information about the patient&#x02019;s health status, medication regimen, outcomes of the MR process, potentially drug-induced symptoms, burden of risks for adverse drug effects, results of laboratory tests and other tests, adherence, and the use of intoxicants, such as alcohol.</p><p>On the basis of the results, the patient&#x02019;s blood pressure, kidney function, and risk of bleeding were clearly considered the 3 most important topics to be documented in a structured form (<xref rid="table2" ref-type="table">Table 2</xref>). Supported by previous research, the experts raised their concern that especially the estimated glomerular filtration rate (eGFR) value is often ignored even though it essentially affects the drug and dosage choices especially in older patients [<xref rid="ref96" ref-type="bibr">96</xref>-<xref rid="ref99" ref-type="bibr">99</xref>]. The structured documentation of the kidney function could also enable the use of electronic decision support systems in medication management in older adults [<xref rid="ref100" ref-type="bibr">100</xref>,<xref rid="ref101" ref-type="bibr">101</xref>]. Our results are in line with the increasing body of evidence indicating the importance of taking the kidney function into account in medicines optimization [<xref rid="ref102" ref-type="bibr">102</xref>]. However, the eGFR value is not yet routinely and easily available to all care team members involved in the implementation of the drug therapy [<xref rid="ref27" ref-type="bibr">27</xref>,<xref rid="ref103" ref-type="bibr">103</xref>,<xref rid="ref104" ref-type="bibr">104</xref>].</p><p>Until now, a major portion of EHR data has consisted of unstructured elements [<xref rid="ref105" ref-type="bibr">105</xref>,<xref rid="ref106" ref-type="bibr">106</xref>]. Structured data has typically included patient demographics, vital signs, laboratory results, diagnostic codes, medication prescriptions, dosages, and administration methods, whereas elements such as clinical notes and discharge summaries have been unstructured. However, our results indicate a shift toward EHR systems that facilitate individual optimization of drug treatments. Updating standard terminology within coding systems, such as LOINC (Regenstrief Institute) and RxNORM (National Library of Medicine), so that they would enable embedding the identified MR items with Health Level 7 Fast Healthcare Interoperability Resources solutions, would thereby be essential [<xref rid="ref107" ref-type="bibr">107</xref>-<xref rid="ref109" ref-type="bibr">109</xref>]. Even though many of the clinical observations related to MRs and basic information about the patient and medicines in use are expressed and documented in standard terminology, there is still a lack of specific terminology for medication use aspects. Such aspects include confirming the patient specific therapeutic suitability and the appropriateness of medications, dosage regimen, administration route, and discontinuation of the medication (deprescribing). Once embedded within Fast Healthcare Interoperability Resources profiles, the exchange and use of more patient-specific MR data would be enabled and made electronically available to care team members, ideally also to community pharmacists while dispensing, counseling, and reviewing medications or contributing in any way to the appropriate and safe medication use [<xref rid="ref110" ref-type="bibr">110</xref>-<xref rid="ref112" ref-type="bibr">112</xref>]. This is particularly important considering aging populations leading to increased comorbidity, polypharmacy, and complex treatments that need to be managed in clinical practice [<xref rid="ref20" ref-type="bibr">20</xref>,<xref rid="ref43" ref-type="bibr">43</xref>-<xref rid="ref48" ref-type="bibr">48</xref>,<xref rid="ref113" ref-type="bibr">113</xref>-<xref rid="ref115" ref-type="bibr">115</xref>].</p><p>Medication adherence topics were rated slightly less important to be documented compared with other datasets. This may be explained by the fact that medication adherence can be considered difficult to measure as it is usually based on patient reporting or claims-based evaluations as proportion of days covered in comparison with more easily measured markers of clinical effect, such as blood pressure or blood coagulation risk [<xref rid="ref116" ref-type="bibr">116</xref>-<xref rid="ref119" ref-type="bibr">119</xref>]. On the other hand, adherence as a behavioral issue may be considered complicated to measure due to a lack of valid and reliable measures feasible to be used in routine clinical practice or to be integrated in EHRs or electronic care pathways [<xref rid="ref120" ref-type="bibr">120</xref>-<xref rid="ref124" ref-type="bibr">124</xref>]. The adherence items identified in this study address behavioral factors related to knowledge and skills in taking medication, beliefs about consequences in taking medication, and negative emotion and beliefs about capabilities in taking medication [<xref rid="ref125" ref-type="bibr">125</xref>]. These items could serve as a short set of questions integrated into the EHR to help assess patients&#x02019; medication taking behaviors and screen for adherence status. This kind of integrated measure could help to identify contributing factors or even root causes to nonadherence and to help plan effective customized physician communication, which is one of the main factors influencing medication adherence [<xref rid="ref126" ref-type="bibr">126</xref>]. Medication adherence is a significant factor affecting real-life effectiveness of drug therapies, as only about 50% of patients treat their long-term condition according to instructions [<xref rid="ref127" ref-type="bibr">127</xref>,<xref rid="ref128" ref-type="bibr">128</xref>]. It would be useful to integrate medication adherence items with other treatment-related adherence measures, such as diet, physical activity, or other lifestyle changes. This extension may provide a more holistic understanding of adherence and disease management problems, enabling also differentiation of medication adherence issues from other treatment adherence issues. In this respect, EHRs should be developed to enable the documentation and monitoring of adherence status and self-management of the treatment to identify problems that should be solved together with the patient [<xref rid="ref126" ref-type="bibr">126</xref>,<xref rid="ref129" ref-type="bibr">129</xref>,<xref rid="ref130" ref-type="bibr">130</xref>].</p><p>The expert panel strongly agreed on having structured MR information in the national Kanta patient information repository, while they commented on several aspects to be considered if the information was made accessible to patients in the MyKanta service. One of the concerns that emerged was the risk of the patients starting independently implementing suggested medication changes without consulting a physician. This concern is in line with physicians&#x02019; previous concerns that the patients&#x02019; access to their own health information, especially if there is not a physician available to interpret the information, may upset patients and cause wrong interpretations [<xref rid="ref131" ref-type="bibr">131</xref>-<xref rid="ref135" ref-type="bibr">135</xref>]. Therefore, previous studies have concluded that not all information should be real-time and that health care professionals should have time to interpret the obtained results and prepare the treatment plans [<xref rid="ref131" ref-type="bibr">131</xref>,<xref rid="ref136" ref-type="bibr">136</xref>,<xref rid="ref137" ref-type="bibr">137</xref>]. However, our results indicate that health care professionals have internalized the positive effects achieved by enabling patient access to their own information. The experts commented that the availability of information in MyKanta could increase the transparency of health care functions and increase a sense of trust. They recommended that the patient could see the final result or a summary of the MR in the MyKanta service but not the possible intermediate stages. These aspects need to be considered when further developing the Kanta and MyKanta services.</p><p>Structuring the identified MR topics could further promote the uniformity and standardization of the MR process and its documentation, which have been called for [<xref rid="ref15" ref-type="bibr">15</xref>,<xref rid="ref79" ref-type="bibr">79</xref>,<xref rid="ref138" ref-type="bibr">138</xref>-<xref rid="ref140" ref-type="bibr">140</xref>]. Organized and easily accessible documentation helps to create an overall picture of the patient&#x02019;s situation so that those participating in the care provision can more easily make use of the previously collected essential information and notice changes in the patient&#x02019;s condition making it easier to plan further treatment and discharge [<xref rid="ref141" ref-type="bibr">141</xref>]. Enhancing the electronic communication between care providers has also proven to be crucial for the large-scale implementation of collaborative MRs [<xref rid="ref142" ref-type="bibr">142</xref>,<xref rid="ref143" ref-type="bibr">143</xref>]. Moreover, structured documentation of patient information could contribute to the secondary use: assessing reliably the effectiveness and cost-effectiveness of MRs, and thereby, possibly supporting their large-scale implementation into the routine clinical practice [<xref rid="ref142" ref-type="bibr">142</xref>,<xref rid="ref144" ref-type="bibr">144</xref>].</p><p>It is, however, important to recognize that although MR practices can benefit from standardization, it is still crucial to maintain flexibility in individualizing MRs according to the context, medical and patient needs, and available resources [<xref rid="ref25" ref-type="bibr">25</xref>,<xref rid="ref144" ref-type="bibr">144</xref>,<xref rid="ref145" ref-type="bibr">145</xref>]. As medication use seldom is black and white, the need for maintaining flexibility also applies to the documentation of MRs. Thus, a combination of freeform text and structured documentation has been called for [<xref rid="ref146" ref-type="bibr">146</xref>,<xref rid="ref147" ref-type="bibr">147</xref>]. To capture clinical and contextual information and interpretations about aspects, such as complexity, severity, or uncertainty, a text box for entering a freeform narrative of the clinical note might be included in an EHR to supplement the structured information [<xref rid="ref148" ref-type="bibr">148</xref>-<xref rid="ref150" ref-type="bibr">150</xref>]. This may apply to parts of MRs where a significant degree of variation occurs hindering the use of a predefined template. Such areas could be explaining the reasons behind nonadherence and self-management problems, describing how identified adherence issues have been resolved or describing the patient&#x02019;s past medical history or the history of the present illness or treatment. To effectively structure the identified MR items, EHR design should focus on key aspects, such as clear labeling of structured fields for ease of use, alignment of data entry processes with clinical workflows, and optimization of user interfaces and interoperability [<xref rid="ref150" ref-type="bibr">150</xref>-<xref rid="ref153" ref-type="bibr">153</xref>].</p></sec><sec><title>Strengths and Limitations</title><p>Our research addresses a very current issue related to the shortcomings of electronic patient information management, particularly information related to medication treatments. The 2 main researchers (TL and NL) thoroughly reviewed previous literature, MR practices, and criteria when preparing for the first Delphi round survey to identify topics that should be documented in a structured form. This was important, because the comprehensiveness and quality of the first round&#x02019;s survey is critical for a successful Delphi study [<xref rid="ref51" ref-type="bibr">51</xref>-<xref rid="ref54" ref-type="bibr">54</xref>]. The comprehensiveness of the preparatory work is supported by the fact that the expert panel proposed only a few new topics and found the presented topics appropriate. To avoid important items being excluded in the case of nonconsensus or the assumption that consensus would automatically imply the correct answer, the results of the study were continuously compared with scientific evidence and the clinical expertise of the research group that ultimately had the final say.</p><p>The expert panel was committed and large in number with a geographical and interprofessional representation. The participation rates remained high throughout the Delphi survey, reflecting commitment and interest in the subject. Of the health care professionals involved, pharmacists were most active, possibly making the results slightly pharmacist oriented. However, due to the strong consensus of the expert panelists, it can be assumed that no great distortion occurred. The lack of patients&#x02019; perspective can be considered a limitation of this study. However, this was a conscious choice made by the researchers at this point as patients cannot be expected to be able to assess the clinical relevance and importance of the MR items presented in the survey in its current form. As members of the research group who ultimately possessed the final say had experience in IT architecture and EHR development, we believe that the absence of EHR vendors in the expert panel did not affect the quality of our research. Even though the Delphi method has proven to be suitable for these kinds of medication safety and risk management studies, the typical methodological limitations of the Delphi method remain [<xref rid="ref51" ref-type="bibr">51</xref>-<xref rid="ref54" ref-type="bibr">54</xref>]. This means that the results represent the views of the expert panel and are dependent on the selection criteria and study process. As the panel consisted of Finnish experts working in the Finnish context, the results as such cannot be directly generalized beyond Finland, but they can be indicative for other countries and their EHR development.</p></sec><sec><title>Practical Implications</title><p>Digital patient information management applications play an increasingly important role in the planning, implementation, monitoring, and optimizing of pharmacotherapies among other health care services. In this study, a carefully built comprehensive list of MR topics was developed based on international literature. This gives EHR developers and clinicians a starting point for further prioritization of topics suitable for different operating settings for both primary and secondary use, even though MR processes in different countries differ in terms of the available patient data, patient involvement, and the purpose of the MR. Such a prioritization has not yet been internationally conducted to any greater extent [<xref rid="ref139" ref-type="bibr">139</xref>]. Our study can contribute to expanding the scope of the more traditionally reviewed MR topics toward a more comprehensive patient-centered direction as well as standardizing the MR process and its documentation.</p><p>Structuring the MR process could also contribute to the effectiveness of MRs and identifying patients benefitting from MRs, thus supporting the large-scale integration of MRs into the standard care [<xref rid="ref142" ref-type="bibr">142</xref>]. The topics related to drug treatment monitoring could prove significant in this regard, as these often represent components that influence the outcomes of MRs [<xref rid="ref141" ref-type="bibr">141</xref>]. This combined with the fast advances in integrating artificial intelligence (AI) tools for natural language processing of free text into EHRs would significantly enhance the MR process [<xref rid="ref154" ref-type="bibr">154</xref>]. This will extend the function of the medication-related documentation in EHRs from a technical data repository toward a prospective clinical decision support system and medication risk management system. The results of this study clarify the issues encountered during the implementation of drug treatments, identify the components of MRs, and highlight which of these components represent critical measures that should be monitored in the patients&#x02019; condition during treatment. In a well-organized information system, these identified factors are quite likely to improve therapeutic outcomes, reduce risks and problems, and increase the efficiency of drug treatment implementation processes.</p></sec><sec><title>Further Research</title><p>In this study, a strong consensus emerged for the structured documentation of a large number of MR topics. The next step in ensuring the clinical feasibility and practical implementation of structured documentation is to define how the information identified in this study should be structured in practice so that the documentation does not become too laborious and time-consuming. Therefore, automated clinical documentation and AI applications should be developed in such a way that compiling and interpreting the information is automated, reliable, and covers the essential information regarding medication treatments [<xref rid="ref139" ref-type="bibr">139</xref>,<xref rid="ref155" ref-type="bibr">155</xref>]. Since not all information can be structured at once, further prioritization is needed. This would enable the use of the structured information for secondary purposes such as identifying patients at risk of developing DRPs and thus benefit from MRs by developing alerts and using AI in automatic screening. Starting with the most prioritized information related to blood pressure, eGFR and the risk of bleeding would seem logical. Involving patients and EHR vendors is an essential prerequisite to ensure that the perspectives and priorities of patients, especially what comes to adherence items, are taken into account in the further development and practical implementation of the structured documentation of MR items. Furthermore, it must be defined which MR information should be made available to patients and what information the patients themselves could document in electronic patient information systems. However, pilots are needed to test new kinds of digital documentation and their use in the medication management system.</p></sec><sec><title>Conclusions</title><p>The committed interprofessional expert panel had a strong consensus on a wide range of MR-related information that should be structurally documented in electronic patient information systems. Further prioritization of the information identified in this study is needed. The expert panel also had a consensus that the MR information should be available to all health care professionals involved in a care team and the patients themselves with some reservations.</p></sec></sec></body><back><ack><p>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Open access funded by Helsinki University Library.</p></ack><fn-group><fn fn-type="con"><p>Authors' Contributions: TL was responsible for study concept and design, data analysis, data interpretation, and drafting and revision of the manuscript for important intellectual content. NL was responsible for study concept and design, data analysis, data interpretation, and revision of the manuscript for important intellectual content. KK, ARH, TT, MU, HN and MA were responsible for study concept and design, data interpretation, and revision of the manuscript for important intellectual content. All authors read and approved the final manuscript.</p></fn><fn fn-type="COI-statement"><p>Conflicts of Interest: None declared.</p></fn></fn-group><app-group><supplementary-material id="app1" position="float" content-type="local-data"><label>Multimedia Appendix 1</label><p>Guidance on Conducting and Reporting of Delphi Studies.</p><media xlink:href="jmir_v27i1e70133_app1.pdf" xlink:title="PDF File (Adobe PDF File), 456 KB" id="d100e1109" position="anchor"/></supplementary-material><supplementary-material id="app2" position="float" content-type="local-data"><label>Multimedia Appendix 2</label><p>The identified medication review (MR) topics (N=108) that should be documented in a structured form in the electronic health record and the MR topics (n=3) for which consensus was not reached.</p><media xlink:href="jmir_v27i1e70133_app2.pdf" xlink:title="PDF File (Adobe PDF File), 411 KB" id="d100e1113" position="anchor"/></supplementary-material></app-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">AI</term><def><p>artificial intelligence</p></def></def-item><def-item><term id="abb2">CREDES</term><def><p>Conducting and REporting DElphi Studies</p></def></def-item><def-item><term id="abb3">DRP</term><def><p>drug-related problem</p></def></def-item><def-item><term id="abb4">eGFR</term><def><p>estimated glomerular filtration rate</p></def></def-item><def-item><term id="abb5">EHR</term><def><p>electronic health record</p></def></def-item><def-item><term id="abb6">MR</term><def><p>medication review</p></def></def-item></def-list></glossary><notes><sec sec-type="data-availability"><title>Data Availability</title><p>The datasets generated or analyzed during this study are available from the corresponding author on reasonable request.</p></sec></notes><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>ME</given-names></name><name><surname>Kelling</surname><given-names>SE</given-names></name><name><surname>Cornelius</surname><given-names>DC</given-names></name><name><surname>Oni</surname><given-names>HA</given-names></name><name><surname>Bright</surname><given-names>DR</given-names></name></person-group><article-title>Enhancing practice efficiency and patient care by sharing electronic health records</article-title><source>Perspect Health Inf Manag</source><year>2015</year><volume>12</volume><issue>Fall</issue><fpage>1b</fpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/26604871" ext-link-type="uri"/>
</comment><pub-id pub-id-type="medline">26604871</pub-id><!--<pub-id pub-id-type="pmcid">PMC4632871</pub-id>--></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delice</surname><given-names>E</given-names></name><name><surname>Polatl&#x00131;</surname><given-names>L&#x000d6;</given-names></name><name><surname>Jbara</surname><given-names>KA</given-names></name><name><surname>Tozan</surname><given-names>H</given-names></name><name><surname>Ert&#x000fc;rk</surname><given-names>A</given-names></name></person-group><article-title>Digitalization in healthcare: a systematic review of the literature</article-title><source>Proceedings</source><year>2023</year><volume>85</volume><issue>1</issue><fpage>26</fpage><comment>
<ext-link xlink:href="https://www.mdpi.com/2504-3900/85/1/26" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.3390/proceedings2023085026</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallio</surname><given-names>S</given-names></name><name><surname>Kumpusalo-Vauhkonen</surname><given-names>A</given-names></name><name><surname>J&#x000e4;rvensivu</surname><given-names>T</given-names></name><name><surname>M&#x000e4;ntyl&#x000e4;</surname><given-names>A</given-names></name><name><surname>Pohjanoksa-M&#x000e4;ntyl&#x000e4;</surname><given-names>M</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name></person-group><article-title>Towards interprofessional networking in medication management of the aged: current challenges and potential solutions in Finland</article-title><source>Scand J Prim Health Care</source><year>2016</year><month>12</month><volume>34</volume><issue>4</issue><fpage>368</fpage><lpage>76</lpage><comment>
<ext-link xlink:href="https://www.tandfonline.com/doi/abs/10.1080/02813432.2016.1249055?url_ver=Z39.88-2003&#x00026;rfr_id=ori:rid:crossref.org&#x00026;rfr_dat=cr_pub0pubmed" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1080/02813432.2016.1249055</pub-id><pub-id pub-id-type="medline">27822968</pub-id><!--<pub-id pub-id-type="pmcid">PMC5217280</pub-id>--><pub-id pub-id-type="pmid">27822968</pub-id>
</element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaipio</surname><given-names>J</given-names></name><name><surname>L&#x000e4;&#x000e4;veri</surname><given-names>T</given-names></name><name><surname>Hypp&#x000f6;nen</surname><given-names>H</given-names></name><name><surname>Vainiom&#x000e4;ki</surname><given-names>S</given-names></name><name><surname>Reponen</surname><given-names>J</given-names></name><name><surname>Kushniruk</surname><given-names>A</given-names></name><name><surname>Borycki</surname><given-names>E</given-names></name><name><surname>V&#x000e4;nsk&#x000e4;</surname><given-names>J</given-names></name></person-group><article-title>Usability problems do not heal by themselves: national survey on physicians' experiences with EHRs in Finland</article-title><source>Int J Med Inform</source><year>2017</year><month>01</month><volume>97</volume><fpage>266</fpage><lpage>81</lpage><comment>
<ext-link xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S1386-5056(16)30225-8" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1016/j.ijmedinf.2016.10.010</pub-id><pub-id pub-id-type="medline">27919385</pub-id><pub-id pub-id-type="pii">S1386-5056(16)30225-8</pub-id><pub-id pub-id-type="pmid">27919385</pub-id>
</element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname><given-names>M</given-names></name><name><surname>Forman</surname><given-names>J</given-names></name><name><surname>Harrod</surname><given-names>M</given-names></name><name><surname>Winter</surname><given-names>S</given-names></name><name><surname>Fowler</surname><given-names>KE</given-names></name><name><surname>Krein</surname><given-names>SL</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Saint</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name><name><surname>Chopra</surname><given-names>V</given-names></name></person-group><article-title>Electronic health records, communication, and data sharing: challenges and opportunities for improving the diagnostic process</article-title><source>Diagnosis (Berl)</source><year>2019</year><month>08</month><day>27</day><volume>6</volume><issue>3</issue><fpage>241</fpage><lpage>8</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/30485175" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1515/dx-2018-0036</pub-id><pub-id pub-id-type="medline">30485175</pub-id><pub-id pub-id-type="pii">/j/dx.ahead-of-print/dx-2018-0036/dx-2018-0036.xml</pub-id><!--<pub-id pub-id-type="pmcid">PMC6691503</pub-id>--><pub-id pub-id-type="pmid">30485175</pub-id>
</element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>TH</given-names></name><name><surname>Zhao</surname><given-names>LP</given-names></name><name><surname>Le</surname><given-names>C</given-names></name><name><surname>Wilcox</surname><given-names>P</given-names></name><name><surname>Yi</surname><given-names>T</given-names></name><name><surname>Hinshaw</surname><given-names>J</given-names></name><name><surname>Hussey</surname><given-names>D</given-names></name><name><surname>Kostrinsky-Thomas</surname><given-names>A</given-names></name><name><surname>Hale</surname><given-names>M</given-names></name><name><surname>Brimm</surname><given-names>J</given-names></name><name><surname>Hisama</surname><given-names>FM</given-names></name></person-group><article-title>Electronic health records contain dispersed risk factor information that could be used to prevent breast and ovarian cancer</article-title><source>J Am Med Inform Assoc</source><year>2020</year><month>07</month><day>01</day><volume>27</volume><issue>9</issue><fpage>1443</fpage><lpage>9</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/32940694" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1093/jamia/ocaa152</pub-id><pub-id pub-id-type="medline">32940694</pub-id><pub-id pub-id-type="pii">5907494</pub-id><!--<pub-id pub-id-type="pmcid">PMC7526466</pub-id>--><pub-id pub-id-type="pmid">32940694</pub-id>
</element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>L</given-names></name><name><surname>Clarke</surname><given-names>J</given-names></name><name><surname>Darzi</surname><given-names>A</given-names></name></person-group><article-title>Measuring the scale of hospital health record system fragmentation in england</article-title><source>Health Serv Res</source><year>2020</year><month>08</month><day>20</day><volume>55</volume><issue>S1</issue><fpage>43</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1111/1475-6773.13386</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>E</given-names></name><name><surname>Clarke</surname><given-names>J</given-names></name><name><surname>Ashrafian</surname><given-names>H</given-names></name><name><surname>Darzi</surname><given-names>A</given-names></name><name><surname>Neves</surname><given-names>AL</given-names></name></person-group><article-title>The impact of electronic health record interoperability on safety and quality of care in high-income countries: systematic review</article-title><source>J Med Internet Res</source><year>2022</year><month>09</month><day>15</day><volume>24</volume><issue>9</issue><fpage>e38144</fpage><comment>
<ext-link xlink:href="https://www.jmir.org/2022/9/e38144/" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.2196/38144</pub-id><pub-id pub-id-type="medline">36107486</pub-id><pub-id pub-id-type="pii">v24i9e38144</pub-id><!--<pub-id pub-id-type="pmcid">PMC9523524</pub-id>--><pub-id pub-id-type="pmid">36107486</pub-id>
</element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinkamp</surname><given-names>J</given-names></name><name><surname>Kantrowitz</surname><given-names>JJ</given-names></name><name><surname>Airan-Javia</surname><given-names>S</given-names></name></person-group><article-title>Prevalence and sources of duplicate information in the electronic medical record</article-title><source>JAMA Netw Open</source><year>2022</year><month>09</month><day>01</day><volume>5</volume><issue>9</issue><fpage>e2233348</fpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/36156143" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.33348</pub-id><pub-id pub-id-type="medline">36156143</pub-id><pub-id pub-id-type="pii">2796664</pub-id><!--<pub-id pub-id-type="pmcid">PMC9513649</pub-id>--><pub-id pub-id-type="pmid">36156143</pub-id>
</element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atasoy</surname><given-names>H</given-names></name><name><surname>Greenwood</surname><given-names>BN</given-names></name><name><surname>McCullough</surname><given-names>JS</given-names></name></person-group><article-title>The digitization of patient care: a review of the effects of electronic health records on health care quality and utilization</article-title><source>Annu Rev Public Health</source><year>2019</year><month>04</month><day>01</day><volume>40</volume><issue>1</issue><fpage>487</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1146/annurev-publhealth-040218-044206</pub-id><pub-id pub-id-type="medline">30566385</pub-id><pub-id pub-id-type="pmid">30566385</pub-id>
</element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000e4;yrinen</surname><given-names>K</given-names></name><name><surname>Saranto</surname><given-names>K</given-names></name><name><surname>Nyk&#x000e4;nen</surname><given-names>P</given-names></name></person-group><article-title>Definition, structure, content, use and impacts of electronic health records: a review of the research literature</article-title><source>Int J Med Inform</source><year>2008</year><month>05</month><volume>77</volume><issue>5</issue><fpage>291</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1016/j.ijmedinf.2007.09.001</pub-id><pub-id pub-id-type="medline">17951106</pub-id><pub-id pub-id-type="pii">S1386-5056(07)00168-2</pub-id><pub-id pub-id-type="pmid">17951106</pub-id>
</element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalra</surname><given-names>F</given-names></name><name><surname>Fernando</surname><given-names>B</given-names></name><name><surname>Morrison</surname><given-names>Z</given-names></name><name><surname>Sheikh</surname><given-names>A</given-names></name></person-group><article-title>A review of the empirical evidence of the value of structuring and coding of clinical information within electronic health records for direct patient care</article-title><source>Inform Prim Care</source><year>2012</year><volume>20</volume><issue>3</issue><fpage>171</fpage><lpage>80</lpage><comment>
<ext-link xlink:href="http://hijournal.bcs.org/index.php/jhi/article/view/22" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.14236/jhi.v20i3.22</pub-id><pub-id pub-id-type="medline">23710841</pub-id><pub-id pub-id-type="pii">22</pub-id><pub-id pub-id-type="pmid">23710841</pub-id>
</element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>BJ</given-names></name><name><surname>Chagin</surname><given-names>KM</given-names></name><name><surname>Nowacki</surname><given-names>AS</given-names></name><name><surname>Kattan</surname><given-names>MW</given-names></name></person-group><article-title>Strategies for handling missing data in electronic health record derived data</article-title><source>EGEMS (Wash DC)</source><year>2013</year><volume>1</volume><issue>3</issue><fpage>1035</fpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/25848578" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.13063/2327-9214.1035</pub-id><pub-id pub-id-type="medline">25848578</pub-id><pub-id pub-id-type="pii">egems1035</pub-id><!--<pub-id pub-id-type="pmcid">PMC4371484</pub-id>--><pub-id pub-id-type="pmid">25848578</pub-id>
</element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsvik</surname><given-names>H</given-names></name><name><surname>Voipio</surname><given-names>V</given-names></name><name><surname>Lamminen</surname><given-names>J</given-names></name><name><surname>Doupi</surname><given-names>P</given-names></name><name><surname>Hypp&#x000f6;nen</surname><given-names>H</given-names></name><name><surname>Vuokko</surname><given-names>R</given-names></name></person-group><article-title>Literature review of patient record structures from the physician's perspective</article-title><source>J Med Syst</source><year>2017</year><month>02</month><day>27</day><volume>41</volume><issue>2</issue><fpage>29</fpage><pub-id pub-id-type="doi">10.1007/s10916-016-0677-0</pub-id><pub-id pub-id-type="medline">28028764</pub-id><pub-id pub-id-type="pii">10.1007/s10916-016-0677-0</pub-id><pub-id pub-id-type="pmid">28028764</pub-id>
</element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vuokko</surname><given-names>R</given-names></name><name><surname>M&#x000e4;kel&#x000e4;-Bengs</surname><given-names>P</given-names></name><name><surname>Hypp&#x000f6;nen</surname><given-names>H</given-names></name><name><surname>Lindqvist</surname><given-names>M</given-names></name><name><surname>Doupi</surname><given-names>P</given-names></name></person-group><article-title>Impacts of structuring the electronic health record: results of a systematic literature review from the perspective of secondary use of patient data</article-title><source>Int J Med Inform</source><year>2017</year><month>01</month><volume>97</volume><fpage>293</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.ijmedinf.2016.10.004</pub-id><pub-id pub-id-type="medline">27919387</pub-id><pub-id pub-id-type="pii">S1386-5056(16)30219-2</pub-id><pub-id pub-id-type="pmid">27919387</pub-id>
</element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferr&#x000e3;o</surname><given-names>JC</given-names></name><name><surname>Oliveira</surname><given-names>MD</given-names></name><name><surname>Janela</surname><given-names>F</given-names></name><name><surname>Martins</surname><given-names>HM</given-names></name><name><surname>Gartner</surname><given-names>D</given-names></name></person-group><article-title>Can structured EHR data support clinical coding? A data mining approach</article-title><source>Health Syst (Basingstoke)</source><year>2020</year><month>03</month><day>01</day><volume>10</volume><issue>2</issue><fpage>138</fpage><lpage>61</lpage><comment>
<ext-link xlink:href="https://www.tandfonline.com/doi/10.1080/20476965.2020.1729666?url_ver=Z39.88-2003&#x00026;rfr_id=ori:rid:crossref.org&#x00026;rfr_dat=cr_pub0pubmed" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1080/20476965.2020.1729666</pub-id><pub-id pub-id-type="medline">34104432</pub-id><pub-id pub-id-type="pii">1729666</pub-id><!--<pub-id pub-id-type="pmcid">PMC8143604</pub-id>--><pub-id pub-id-type="pmid">34104432</pub-id>
</element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fennelly</surname><given-names>O</given-names></name><name><surname>Cunningham</surname><given-names>C</given-names></name><name><surname>Grogan</surname><given-names>L</given-names></name><name><surname>Cronin</surname><given-names>H</given-names></name><name><surname>O'Shea</surname><given-names>C</given-names></name><name><surname>Roche</surname><given-names>M</given-names></name><name><surname>Lawlor</surname><given-names>F</given-names></name><name><surname>O'Hare</surname><given-names>N</given-names></name></person-group><article-title>Successfully implementing a national electronic health record: a rapid umbrella review</article-title><source>Int J Med Inform</source><year>2020</year><month>12</month><volume>144</volume><fpage>104281</fpage><comment>
<ext-link xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S1386-5056(20)31065-0" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1016/j.ijmedinf.2020.104281</pub-id><pub-id pub-id-type="medline">33017724</pub-id><pub-id pub-id-type="pii">S1386-5056(20)31065-0</pub-id><!--<pub-id pub-id-type="pmcid">PMC7510429</pub-id>--><pub-id pub-id-type="pmid">33017724</pub-id>
</element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manskow</surname><given-names>US</given-names></name><name><surname>Kristiansen</surname><given-names>TT</given-names></name></person-group><article-title>Challenges faced by health professionals in obtaining correct medication information in the absence of a shared digital medication list</article-title><source>Pharmacy (Basel)</source><year>2021</year><month>02</month><day>22</day><volume>9</volume><issue>1</issue><fpage>46</fpage><comment>
<ext-link xlink:href="https://www.mdpi.com/resolver?pii=pharmacy9010046" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.3390/pharmacy9010046</pub-id><pub-id pub-id-type="medline">33671820</pub-id><pub-id pub-id-type="pii">pharmacy9010046</pub-id><!--<pub-id pub-id-type="pmcid">PMC8006028</pub-id>--><pub-id pub-id-type="pmid">33671820</pub-id>
</element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hepler</surname><given-names>CD</given-names></name><name><surname>Strand</surname><given-names>LM</given-names></name></person-group><article-title>Opportunities and responsibilities in pharmaceutical care</article-title><source>Am J Hosp Pharm</source><year>1990</year><month>03</month><day>01</day><volume>47</volume><issue>3</issue><fpage>533</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1093/ajhp/47.3.533</pub-id><pub-id pub-id-type="pmid">2316538</pub-id>
</element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leikola</surname><given-names>S</given-names></name><name><surname>Tuomainen</surname><given-names>L</given-names></name><name><surname>Peura</surname><given-names>S</given-names></name><name><surname>Laurikainen</surname><given-names>A</given-names></name><name><surname>Lyles</surname><given-names>A</given-names></name><name><surname>Savela</surname><given-names>E</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name></person-group><article-title>Comprehensive medication review: development of a collaborative procedure</article-title><source>Int J Clin Pharm</source><year>2012</year><month>08</month><volume>34</volume><issue>4</issue><fpage>510</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1007/s11096-012-9662-y</pub-id><pub-id pub-id-type="medline">22711383</pub-id><pub-id pub-id-type="pmid">22711383</pub-id>
</element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dimitrow</surname><given-names>SM</given-names></name></person-group><source>Development and validation of a drug-related problem risk assessment tool for use by practical nurses working with community-dwelling aged. Dissertation</source><year>2016</year><date-in-citation content-type="access-date">2024-10-09</date-in-citation><publisher-name>University of Helsinki</publisher-name><comment>
<ext-link xlink:href="https://helda.helsinki.fi/items/185e2d7a-36e5-46f3-85e6-3c95374d9170" ext-link-type="uri">https://helda.helsinki.fi/items/185e2d7a-36e5-46f3-85e6-3c95374d9170</ext-link>
</comment></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griese-Mammen</surname><given-names>N</given-names></name><name><surname>Hersberger</surname><given-names>KE</given-names></name><name><surname>Messerli</surname><given-names>M</given-names></name><name><surname>Leikola</surname><given-names>S</given-names></name><name><surname>Horvat</surname><given-names>N</given-names></name><name><surname>van Mil</surname><given-names>JW</given-names></name><name><surname>Kos</surname><given-names>M</given-names></name></person-group><article-title>PCNE definition of medication review: reaching agreement</article-title><source>Int J Clin Pharm</source><year>2018</year><month>10</month><volume>40</volume><issue>5</issue><fpage>1199</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1007/s11096-018-0696-7</pub-id><pub-id pub-id-type="medline">30073611</pub-id><pub-id pub-id-type="pii">10.1007/s11096-018-0696-7</pub-id><pub-id pub-id-type="pmid">30073611</pub-id>
</element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schepel</surname><given-names>L</given-names></name><name><surname>Aronpuro</surname><given-names>K</given-names></name><name><surname>Kvarnstr&#x000f6;m</surname><given-names>K</given-names></name><name><surname>Holmstr&#x000f6;m</surname><given-names>AR</given-names></name><name><surname>Lehtonen</surname><given-names>L</given-names></name><name><surname>Lapatto-Reiniluoto</surname><given-names>O</given-names></name><name><surname>Laaksonen</surname><given-names>R</given-names></name><name><surname>Carlsson</surname><given-names>K</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name></person-group><article-title>Strategies for improving medication safety in hospitals: evolution of clinical pharmacy services</article-title><source>Res Soc Adm Pharm</source><year>2019</year><month>07</month><volume>15</volume><issue>7</issue><fpage>873</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.sapharm.2019.02.004</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulajeva</surname><given-names>A</given-names></name><name><surname>Labberton</surname><given-names>L</given-names></name><name><surname>Leikola</surname><given-names>S</given-names></name><name><surname>Pohjanoksa-M&#x000e4;ntyl&#x000e4;</surname><given-names>M</given-names></name><name><surname>Geurts</surname><given-names>MM</given-names></name><name><surname>de Gier</surname><given-names>JJ</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name></person-group><article-title>Medication review practices in European countries</article-title><source>Res Social Adm Pharm</source><year>2014</year><volume>10</volume><issue>5</issue><fpage>731</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.sapharm.2014.02.005</pub-id><pub-id pub-id-type="medline">24661800</pub-id><pub-id pub-id-type="pii">S1551-7411(14)00029-1</pub-id><pub-id pub-id-type="pmid">24661800</pub-id>
</element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiiski</surname><given-names>A</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name><name><surname>M&#x000e4;ntyl&#x000e4;</surname><given-names>A</given-names></name><name><surname>Desselle</surname><given-names>S</given-names></name><name><surname>Kumpusalo-Vauhkonen</surname><given-names>A</given-names></name><name><surname>J&#x000e4;rvensivu</surname><given-names>T</given-names></name><name><surname>Pohjanoksa-M&#x000e4;ntyl&#x000e4;</surname><given-names>M</given-names></name></person-group><article-title>An inventory of collaborative medication reviews for older adults - evolution of practices</article-title><source>BMC Geriatr</source><year>2019</year><month>11</month><day>21</day><volume>19</volume><issue>1</issue><fpage>321</fpage><comment>
<ext-link xlink:href="https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-019-1317-6" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1186/s12877-019-1317-6</pub-id><pub-id pub-id-type="medline">31752700</pub-id><pub-id pub-id-type="pii">10.1186/s12877-019-1317-6</pub-id><!--<pub-id pub-id-type="pmcid">PMC6873748</pub-id>--><pub-id pub-id-type="pmid">31752700</pub-id>
</element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imfeld-Isenegger</surname><given-names>TL</given-names></name><name><surname>Soares</surname><given-names>IB</given-names></name><name><surname>Makovec</surname><given-names>UN</given-names></name><name><surname>Horvat</surname><given-names>N</given-names></name><name><surname>Kos</surname><given-names>M</given-names></name><name><surname>van Mil</surname><given-names>F</given-names></name><name><surname>Costa</surname><given-names>FA</given-names></name><name><surname>Hersberger</surname><given-names>KE</given-names></name></person-group><article-title>Community pharmacist-led medication review procedures across Europe: characterization, implementation and remuneration</article-title><source>Res Soc Adm Pharm</source><year>2020</year><month>08</month><volume>16</volume><issue>8</issue><fpage>1057</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.sapharm.2019.11.002</pub-id><pub-id pub-id-type="medline">31734100</pub-id><pub-id pub-id-type="pii">S1551-7411(19)30523-6</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallio</surname><given-names>SE</given-names></name><name><surname>Kiiski</surname><given-names>A</given-names></name><name><surname>Airaksinen</surname><given-names>MS</given-names></name><name><surname>M&#x000e4;ntyl&#x000e4;</surname><given-names>AT</given-names></name><name><surname>Kumpusalo-Vauhkonen</surname><given-names>AE</given-names></name><name><surname>J&#x000e4;rvensivu</surname><given-names>TP</given-names></name><name><surname>Pohjanoksa-M&#x000e4;ntyl&#x000e4;</surname><given-names>MK</given-names></name></person-group><article-title>Community pharmacists' contribution to medication reviews for older adults: a systematic review</article-title><source>J Am Geriatr Soc</source><year>2018</year><month>08</month><volume>66</volume><issue>8</issue><fpage>1613</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1111/jgs.15416</pub-id><pub-id pub-id-type="medline">29972691</pub-id><pub-id pub-id-type="pmid">29972691</pub-id>
</element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercer</surname><given-names>K</given-names></name><name><surname>Burns</surname><given-names>C</given-names></name><name><surname>Guirguis</surname><given-names>L</given-names></name><name><surname>Chin</surname><given-names>J</given-names></name><name><surname>Dogba</surname><given-names>MJ</given-names></name><name><surname>Dolovich</surname><given-names>L</given-names></name><name><surname>Gu&#x000e9;nette</surname><given-names>L</given-names></name><name><surname>Jenkins</surname><given-names>L</given-names></name><name><surname>L&#x000e9;gar&#x000e9;</surname><given-names>F</given-names></name><name><surname>McKinnon</surname><given-names>A</given-names></name><name><surname>McMurray</surname><given-names>J</given-names></name><name><surname>Waked</surname><given-names>K</given-names></name><name><surname>Grindrod</surname><given-names>KA</given-names></name></person-group><article-title>Physician and pharmacist medication decision-making in the time of electronic health records: mixed-methods study</article-title><source>JMIR Hum Factors</source><year>2018</year><month>09</month><day>25</day><volume>5</volume><issue>3</issue><fpage>e24</fpage><comment>
<ext-link xlink:href="https://humanfactors.jmir.org/2018/3/e24/" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.2196/humanfactors.9891</pub-id><pub-id pub-id-type="medline">30274959</pub-id><pub-id pub-id-type="pii">v5i3e24</pub-id><!--<pub-id pub-id-type="pmcid">PMC6231837</pub-id>--><pub-id pub-id-type="pmid">30274959</pub-id>
</element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname> Keskim&#x000e4;ki</surname><given-names>I</given-names></name><name><surname>Tynkkynen</surname><given-names>LK</given-names></name><name><surname>Reissell</surname><given-names>E</given-names></name><name><surname>Koivusalo</surname><given-names>M</given-names></name><name><surname>Syrj&#x000e4;</surname><given-names>V</given-names></name><name><surname>Vuorenkoski</surname><given-names>L</given-names></name><name><surname>Rechel</surname><given-names>B</given-names></name><name><surname>Karanikolos</surname><given-names>M</given-names></name></person-group><article-title>Finland: health system review</article-title><source>Health Syst Transit</source><year>2019</year><volume>21</volume><issue>2</issue><fpage>1</fpage><lpage>166</lpage><comment>
<ext-link xlink:href="https://apps.who.int/iris/bitstream/handle/10665/327538/HiT-21-2-2019-eng.pdf" ext-link-type="uri"/>
</comment></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Ministry of Social Affairs and Health</collab></person-group><article-title>National service reform: reform of the content and operating methods of health and social services</article-title><date-in-citation content-type="access-date">2024-11-13</date-in-citation><comment>
<ext-link xlink:href="https://stm.fi/en/national-service-reform" ext-link-type="uri">https://stm.fi/en/national-service-reform</ext-link>
</comment></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Ministry of Social Affairs and Health</collab></person-group><article-title>Reports and Memorandums of the Ministry of Social Affairs and Health 19/2018</article-title><source>Rational Pharmacotherapy Action Plan. Final report</source><year>2018</year><date-in-citation content-type="access-date">2024-05-03</date-in-citation><comment>
<ext-link xlink:href="http://urn.fi/URN:ISBN:978-952-00-3930-1" ext-link-type="uri">http://urn.fi/URN:ISBN:978-952-00-3930-1</ext-link>
</comment></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Ministry of Social Affairs and Health</collab></person-group><article-title>Points of views on Need for Changes in Medication and Distribution system of Medicines Memorandum</article-title><source>Sosiaali- ja Terveysministeri&#x000f6; Helsinki</source><year>2019</year><date-in-citation content-type="access-date">2024-08-19</date-in-citation><comment>
<ext-link xlink:href="https://julkaisut.valtioneuvosto.fi/bitstream/handle/10024/161340/STM_Rap_5_2019.pdf?sequence=1&#x00026;isAllowed=y" ext-link-type="uri">https://julkaisut.valtioneuvosto.fi/bitstream/handle/10024/161340/STM_Rap_5_2019.pdf?sequence=1&#x00026;isAllowed=y</ext-link>
</comment></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jormanainen</surname><given-names>V</given-names></name></person-group><article-title>Large-scale implementation and adoption of the Finnish national Kanta services in 2010&#x02013;2017: a prospective, longitudinal, indicator-based study</article-title><source>Fin J EHealth EWelfare</source><year>2018</year><month>12</month><day>04</day><volume>10</volume><issue>4</issue><fpage>381</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.23996/fjhw.74511</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mononen</surname><given-names>N</given-names></name></person-group><source>From paper to cyber: medicines information as a strategic goal in Finland and the European Union. Dissertation</source><year>2020</year><date-in-citation content-type="access-date">2024-08-02</date-in-citation><publisher-name>University of Helsinki</publisher-name><comment>
<ext-link xlink:href="https://helda.helsinki.fi/items/6ad9f259-5bcb-4b4f-9b56-6cab7e73f59c" ext-link-type="uri">https://helda.helsinki.fi/items/6ad9f259-5bcb-4b4f-9b56-6cab7e73f59c</ext-link>
</comment></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kallio</surname><given-names>S</given-names></name></person-group><source>Community pharmacists&#x02019; contribution to prospective medication risk management for older adults in the context of network theory. Dissertation</source><year>2021</year><date-in-citation content-type="access-date">2024-09-14</date-in-citation><publisher-name>University of Helsinki</publisher-name><comment>
<ext-link xlink:href="https://helda.helsinki.fi/items/eedbeeb8-e242-4f8e-881b-23501f908b39" ext-link-type="uri">https://helda.helsinki.fi/items/eedbeeb8-e242-4f8e-881b-23501f908b39</ext-link>
</comment></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heponiemi</surname><given-names>T</given-names></name><name><surname>Hypp&#x000f6;nen</surname><given-names>H</given-names></name><name><surname>Vehko</surname><given-names>T</given-names></name><name><surname>Kujala</surname><given-names>S</given-names></name><name><surname>Aalto</surname><given-names>AM</given-names></name><name><surname>V&#x000e4;nsk&#x000e4;</surname><given-names>J</given-names></name><name><surname>Elovainio</surname><given-names>M</given-names></name></person-group><article-title>Finnish physicians' stress related to information systems keeps increasing: a longitudinal three-wave survey study</article-title><source>BMC Med Inform Decis Mak</source><year>2017</year><month>10</month><day>17</day><volume>17</volume><issue>1</issue><fpage>147</fpage><comment>
<ext-link xlink:href="https://bmcmedinformdecismak.biomedcentral.com/articles/10.1186/s12911-017-0545-y" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1186/s12911-017-0545-y</pub-id><pub-id pub-id-type="medline">29041971</pub-id><pub-id pub-id-type="pii">10.1186/s12911-017-0545-y</pub-id><!--<pub-id pub-id-type="pmcid">PMC5646125</pub-id>--><pub-id pub-id-type="pmid">29041971</pub-id>
</element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="webpage"><article-title>Kanta homepage</article-title><source>Kanta</source><date-in-citation content-type="access-date">2024-05-30</date-in-citation><comment>
<ext-link xlink:href="https://www.kanta.fi/en/" ext-link-type="uri">https://www.kanta.fi/en/</ext-link>
</comment></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="webpage"><article-title>Act on electronic prescriptions 61/2007</article-title><source>Finlex</source><date-in-citation content-type="access-date">2024-12-17</date-in-citation><comment>
<ext-link xlink:href="https://www.finlex.fi/fi/lainsaadanto/2007/61" ext-link-type="uri">https://www.finlex.fi/fi/lainsaadanto/2007/61</ext-link>
</comment></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hypp&#x000f6;nen</surname><given-names>H</given-names></name><name><surname>Vuokko</surname><given-names>R</given-names></name><name><surname>Doupi</surname><given-names>P</given-names></name><name><surname>M&#x000e4;kel&#x000e4;-Bengs</surname><given-names>P</given-names></name></person-group><source>Structuring of the Electronic Patient Record. Methods, Assessment Practices and Impacts</source><year>2014</year><date-in-citation content-type="access-date">2024-05-27</date-in-citation><publisher-loc>Helsinki, Finland</publisher-loc><publisher-name>National Institute for Health and Welfare</publisher-name><comment>
<ext-link xlink:href="https://urn.fi/URN:ISBN:978-952-302-381-9" ext-link-type="uri">https://urn.fi/URN:ISBN:978-952-302-381-9</ext-link>
</comment></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Virkkunen</surname><given-names>H</given-names></name><name><surname>Palvimo</surname><given-names>J</given-names></name></person-group><article-title>The concept of medication treatment information management</article-title><source>The Finnish Institute for Health and Welfare</source><year>2024</year><month>12</month><date-in-citation content-type="access-date">2024-12-16</date-in-citation><comment>
<ext-link xlink:href="https://www.julkari.fi/bitstream/handle/10024/150221/L%c3%a4%c3%a4kehoidon%20tiedonhallinnan%20konsepti-v2-20241216.pdf?sequence=1&#x00026;isAllowed=y" ext-link-type="uri">https://www.julkari.fi/bitstream/handle/10024/150221/L%c3%a4%c3%a4kehoidon%20tiedonhallinnan%20konsepti-v2-20241216.pdf?sequence=1&#x00026;isAllowed=y</ext-link>
</comment></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaipio</surname><given-names>J</given-names></name><name><surname>Kuusisto</surname><given-names>A</given-names></name><name><surname>Hypp&#x000f6;nen</surname><given-names>H</given-names></name><name><surname>Heponiemi</surname><given-names>T</given-names></name><name><surname>L&#x000e4;&#x000e4;veri</surname><given-names>T</given-names></name></person-group><article-title>Physicians' and nurses' experiences on EHR usability: comparison between the professional groups by employment sector and system brand</article-title><source>Int J Med Inform</source><year>2020</year><month>02</month><volume>134</volume><fpage>104018</fpage><comment>
<ext-link xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S1386-5056(19)30683-5" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1016/j.ijmedinf.2019.104018</pub-id><pub-id pub-id-type="medline">31835158</pub-id><pub-id pub-id-type="pii">S1386-5056(19)30683-5</pub-id><pub-id pub-id-type="pmid">31835158</pub-id>
</element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="webpage"><article-title>Statistical yearbook on social welfare and health care 2021</article-title><source>Finnish Institute for Health and Welfare</source><year>2021</year><date-in-citation content-type="access-date">2024-08-18</date-in-citation><comment>
<ext-link xlink:href="https://www.julkari.fi/handle/10024/143537" ext-link-type="uri">https://www.julkari.fi/handle/10024/143537</ext-link>
</comment></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitkala</surname><given-names>KH</given-names></name><name><surname>Juola</surname><given-names>AL</given-names></name><name><surname>Hosia</surname><given-names>H</given-names></name><name><surname>Teramura-Gronblad</surname><given-names>M</given-names></name><name><surname>Soini</surname><given-names>H</given-names></name><name><surname>Savikko</surname><given-names>N</given-names></name><name><surname>Bell</surname><given-names>JS</given-names></name></person-group><article-title>Eight-year trends in the use of opioids, other analgesics, and psychotropic medications among institutionalized older people in Finland</article-title><source>J Am Med Dir Assoc</source><year>2015</year><month>11</month><day>01</day><volume>16</volume><issue>11</issue><fpage>973</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jamda.2015.06.009</pub-id><pub-id pub-id-type="medline">26170037</pub-id><pub-id pub-id-type="pii">S1525-8610(15)00420-X</pub-id><pub-id pub-id-type="pmid">26170037</pub-id>
</element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juola</surname><given-names>AL</given-names></name><name><surname>Pylkkanen</surname><given-names>S</given-names></name><name><surname>Kautiainen</surname><given-names>H</given-names></name><name><surname>Bell</surname><given-names>JS</given-names></name><name><surname>Bjorkman</surname><given-names>MP</given-names></name><name><surname>Finne-Soveri</surname><given-names>H</given-names></name><name><surname>Soini</surname><given-names>H</given-names></name><name><surname>Pitk&#x000e4;l&#x000e4;</surname><given-names>KH</given-names></name></person-group><article-title>Burden of potentially harmful medications and the association with quality of life and mortality among institutionalized older people</article-title><source>J Am Med Dir Assoc</source><year>2016</year><month>03</month><day>01</day><volume>17</volume><issue>3</issue><fpage>276.e9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.jamda.2015.12.011</pub-id><pub-id pub-id-type="medline">26805751</pub-id><pub-id pub-id-type="pii">S1525-8610(15)00761-6</pub-id></element-citation></ref><ref id="ref45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auvinen</surname><given-names>K</given-names></name><name><surname>R&#x000e4;is&#x000e4;nen</surname><given-names>J</given-names></name><name><surname>Merikoski</surname><given-names>M</given-names></name><name><surname>M&#x000e4;ntyl&#x000e4;</surname><given-names>A</given-names></name><name><surname>Kumpusalo-Vauhkonen</surname><given-names>A</given-names></name><name><surname>Enlund</surname><given-names>H</given-names></name><name><surname>Liukkonen</surname><given-names>T</given-names></name><name><surname>Jyrkk&#x000e4;</surname><given-names>J</given-names></name><name><surname>L&#x000f6;nnroos</surname><given-names>E</given-names></name><name><surname>M&#x000e4;ntyselk&#x000e4;</surname><given-names>P</given-names></name></person-group><article-title>The Finnish Interprofessional Medication Assessment (FIMA): baseline findings from home care setting</article-title><source>Aging Clin Exp Res</source><year>2019</year><month>10</month><volume>31</volume><issue>10</issue><fpage>1471</fpage><lpage>9</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/30519976" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1007/s40520-018-1085-8</pub-id><pub-id pub-id-type="medline">30519976</pub-id><pub-id pub-id-type="pii">10.1007/s40520-018-1085-8</pub-id><!--<pub-id pub-id-type="pmcid">PMC6763522</pub-id>--><pub-id pub-id-type="pmid">30519976</pub-id>
</element-citation></ref><ref id="ref46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jalava</surname><given-names>SE</given-names></name><name><surname>Pohjanoksa-M&#x000e4;ntyl&#x000e4;</surname><given-names>M</given-names></name><name><surname>Puustinen</surname><given-names>J</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name><name><surname>Dimitrow</surname><given-names>MS</given-names></name></person-group><article-title>Psykoosil&#x000e4;&#x000e4;kkeiden k&#x000e4;ytt&#x000f6; i&#x000e4;kk&#x000e4;ill&#x000e4; : j&#x000e4;rjestelm&#x000e4;llinen katsaus [Use of antipsychotics among older adults in Finland: a systematic review]</article-title><source>Suomen l&#x000e4;&#x000e4;k&#x000e4;rilehti</source><year>2018</year><volume>73</volume><issue>33</issue><fpage>1743</fpage><lpage>9</lpage><comment>
<ext-link xlink:href="https://helda-test-22.hulib.helsinki.fi/server/api/core/bitstreams/e281a057-f888-480f-9e21-6f3cd91fe9c1/content" ext-link-type="uri"/>
</comment></element-citation></ref><ref id="ref47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurko</surname><given-names>T</given-names></name><name><surname>Saastamoinen</surname><given-names>LK</given-names></name><name><surname>Tuulio-Henriksson</surname><given-names>A</given-names></name><name><surname>Taiminen</surname><given-names>T</given-names></name><name><surname>Tiihonen</surname><given-names>J</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name><name><surname>Hietala</surname><given-names>J</given-names></name></person-group><article-title>Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: a national register study for 2006 to 2014</article-title><source>Pharmacoepidemiol Drug Saf</source><year>2018</year><month>06</month><volume>27</volume><issue>6</issue><fpage>674</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1002/pds.4551</pub-id><pub-id pub-id-type="medline">29726630</pub-id><pub-id pub-id-type="pmid">29726630</pub-id>
</element-citation></ref><ref id="ref48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toivo</surname><given-names>T</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name><name><surname>Dimitrow</surname><given-names>M</given-names></name><name><surname>Savela</surname><given-names>E</given-names></name><name><surname>Pelkonen</surname><given-names>K</given-names></name><name><surname>Kiuru</surname><given-names>V</given-names></name><name><surname>Suominen</surname><given-names>T</given-names></name><name><surname>Uunim&#x000e4;ki</surname><given-names>M</given-names></name><name><surname>Kivel&#x000e4;</surname><given-names>SL</given-names></name><name><surname>Leikola</surname><given-names>S</given-names></name><name><surname>Puustinen</surname><given-names>J</given-names></name></person-group><article-title>Enhanced coordination of care to reduce medication risks in older home care clients in primary care: a randomized controlled trial</article-title><source>BMC Geriatr</source><year>2019</year><month>11</month><day>27</day><volume>19</volume><issue>1</issue><fpage>332</fpage><comment>
<ext-link xlink:href="https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-019-1353-2" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1186/s12877-019-1353-2</pub-id><pub-id pub-id-type="medline">31775650</pub-id><pub-id pub-id-type="pii">10.1186/s12877-019-1353-2</pub-id><!--<pub-id pub-id-type="pmcid">PMC6882364</pub-id>--><pub-id pub-id-type="pmid">31775650</pub-id>
</element-citation></ref><ref id="ref49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimitrow</surname><given-names>MS</given-names></name><name><surname>Mykk&#x000e4;nen</surname><given-names>SI</given-names></name><name><surname>Leikola</surname><given-names>SN</given-names></name><name><surname>Kivel&#x000e4;</surname><given-names>SL</given-names></name><name><surname>Lyles</surname><given-names>A</given-names></name><name><surname>Airaksinen</surname><given-names>MS</given-names></name></person-group><article-title>Content validation of a tool for assessing risks for drug-related problems to be used by practical nurses caring for home-dwelling clients aged &#x02265;65&#x000a0;years: a Delphi survey</article-title><source>Eur J Clin Pharmacol</source><year>2014</year><month>08</month><volume>70</volume><issue>8</issue><fpage>991</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1007/s00228-014-1699-5</pub-id><pub-id pub-id-type="medline">24879605</pub-id><pub-id pub-id-type="pmid">24879605</pub-id>
</element-citation></ref><ref id="ref50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>The National Coordination Group of Professional Development of Pharmacy Services (AATE)</collab></person-group><article-title>Medication review competence recommendations for pharmacists working in community pharmacies and other health care settings (English summary)</article-title><source>Dosis</source><year>2017</year><volume>33</volume><issue>3</issue><fpage>199</fpage><lpage>209</lpage><comment>
<ext-link xlink:href="https://dosis.fi/wp-content/uploads/2018/03/Dosis_3_2017.pdf" ext-link-type="uri"/>
</comment></element-citation></ref><ref id="ref51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalkey</surname><given-names>N</given-names></name><name><surname>Helmer</surname><given-names>O</given-names></name></person-group><article-title>An experimental application of the DELPHI method to the use of experts</article-title><source>Manag Sci</source><year>1963</year><month>04</month><volume>9</volume><issue>3</issue><fpage>458</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1287/mnsc.9.3.458</pub-id></element-citation></ref><ref id="ref52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>SM</given-names></name><name><surname>Cantrill</surname><given-names>JA</given-names></name></person-group><article-title>Consensus methods in prescribing research</article-title><source>J Clin Pharm Ther</source><year>2001</year><month>02</month><day>15</day><volume>26</volume><issue>1</issue><fpage>5</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2710.2001.00331.x</pub-id><pub-id pub-id-type="medline">11286603</pub-id><pub-id pub-id-type="pii">jcp331</pub-id><pub-id pub-id-type="pmid">11286603</pub-id>
</element-citation></ref><ref id="ref53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okoli</surname><given-names>C</given-names></name><name><surname>Pawlowski</surname><given-names>SD</given-names></name></person-group><article-title>The Delphi method as a research tool: an example, design considerations and applications</article-title><source>Inf Manag</source><year>2004</year><month>12</month><volume>42</volume><issue>1</issue><fpage>15</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.im.2003.11.002</pub-id></element-citation></ref><ref id="ref54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>CC</given-names></name><name><surname>Sandford</surname><given-names>BA</given-names></name></person-group><article-title>The Delphi technique: making sense of consensus</article-title><source>Pract Assess Res Eval</source><year>2007</year><volume>12</volume><issue>1</issue><fpage>10</fpage><comment>
<ext-link xlink:href="https://openpublishing.library.umass.edu/pare/article/id/1418/" ext-link-type="uri"/>
</comment></element-citation></ref><ref id="ref55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beers</surname><given-names>MH</given-names></name><name><surname>Ouslander</surname><given-names>JG</given-names></name><name><surname>Rollingher</surname><given-names>I</given-names></name><name><surname>Reuben</surname><given-names>DB</given-names></name><name><surname>Brooks</surname><given-names>J</given-names></name><name><surname>Beck</surname><given-names>JC</given-names></name></person-group><article-title>Explicit criteria for determining inappropriate medication use in nursing home residents</article-title><source>Arch Intern Med</source><year>1991</year><month>09</month><day>01</day><volume>151</volume><issue>9</issue><fpage>1825</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1001/archinte.1991.00400090107019</pub-id><pub-id pub-id-type="pmid">1888249</pub-id>
</element-citation></ref><ref id="ref56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beers</surname><given-names>MH</given-names></name></person-group><article-title>Explicit criteria for determining potentially inappropriate medication use by the elderly</article-title><source>Arch Intern Med</source><year>1997</year><month>07</month><day>28</day><volume>157</volume><issue>14</issue><fpage>1531</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1001/archinte.1997.00440350031003</pub-id><pub-id pub-id-type="pmid">9236554</pub-id>
</element-citation></ref><ref id="ref57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLeod</surname><given-names>PJ</given-names></name><name><surname>Huang</surname><given-names>AR</given-names></name><name><surname>Tamblyn</surname><given-names>RM</given-names></name><name><surname>Gayton</surname><given-names>DC</given-names></name></person-group><article-title>Defining inappropriate practices in prescribing for elderly people: a national consensus panel</article-title><source>CMAJ</source><year>1997</year><month>02</month><day>01</day><volume>156</volume><issue>3</issue><fpage>385</fpage><lpage>91</lpage><comment>
<ext-link xlink:href="http://www.cmaj.ca/cgi/pmidlookup?view=reprint&#x00026;pmid=9033421" ext-link-type="uri"/>
</comment><pub-id pub-id-type="medline">9033421</pub-id><!--<pub-id pub-id-type="pmcid">PMC1226961</pub-id>--><pub-id pub-id-type="pmid">9033421</pub-id>
</element-citation></ref><ref id="ref58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naugler</surname><given-names>CT</given-names></name><name><surname>Brymer</surname><given-names>C</given-names></name><name><surname>Stolee</surname><given-names>P</given-names></name><name><surname>Arcese</surname><given-names>ZA</given-names></name></person-group><article-title>Development and validation of an improving prescribing in the elderly tool</article-title><source>Can J Clin Pharmacol</source><year>2000</year><volume>7</volume><issue>2</issue><fpage>103</fpage><lpage>7</lpage><pub-id pub-id-type="medline">10958706</pub-id><pub-id pub-id-type="pmid">10958706</pub-id>
</element-citation></ref><ref id="ref59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fick</surname><given-names>DM</given-names></name><name><surname>Cooper</surname><given-names>JW</given-names></name><name><surname>Wade</surname><given-names>WE</given-names></name><name><surname>Waller</surname><given-names>JL</given-names></name><name><surname>Maclean</surname><given-names>JR</given-names></name><name><surname>Beers</surname><given-names>MH</given-names></name></person-group><article-title>Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts</article-title><source>Arch Intern Med</source><year>2003</year><month>12</month><day>08</day><volume>163</volume><issue>22</issue><fpage>2716</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1001/archinte.163.22.2716</pub-id><pub-id pub-id-type="medline">14662625</pub-id><pub-id pub-id-type="pii">163/22/2716</pub-id><pub-id pub-id-type="pmid">14662625</pub-id>
</element-citation></ref><ref id="ref60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallagher</surname><given-names>P</given-names></name><name><surname>Ryan</surname><given-names>C</given-names></name><name><surname>Byrne</surname><given-names>S</given-names></name><name><surname>Kennedy</surname><given-names>J</given-names></name><name><surname>O'Mahony</surname><given-names>D</given-names></name></person-group><article-title>STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation</article-title><source>Int J Clin Pharmacol Ther</source><year>2008</year><month>02</month><volume>46</volume><issue>2</issue><fpage>72</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.5414/cpp46072</pub-id><pub-id pub-id-type="medline">18218287</pub-id><pub-id pub-id-type="pmid">18218287</pub-id>
</element-citation></ref><ref id="ref61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rognstad</surname><given-names>S</given-names></name><name><surname>Brekke</surname><given-names>M</given-names></name><name><surname>Fetveit</surname><given-names>A</given-names></name><name><surname>Spigset</surname><given-names>O</given-names></name><name><surname>Wyller</surname><given-names>TB</given-names></name><name><surname>Straand</surname><given-names>J</given-names></name></person-group><article-title>The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study</article-title><source>Scand J Prim Health Care</source><year>2009</year><month>09</month><day>09</day><volume>27</volume><issue>3</issue><fpage>153</fpage><lpage>9</lpage><comment>
<ext-link xlink:href="https://www.tandfonline.com/doi/10.1080/02813430902992215?url_ver=Z39.88-2003&#x00026;rfr_id=ori:rid:crossref.org&#x00026;rfr_dat=cr_pub0pubmed" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1080/02813430902992215</pub-id><pub-id pub-id-type="medline">19462339</pub-id><pub-id pub-id-type="pii">911595840</pub-id><!--<pub-id pub-id-type="pmcid">PMC3413187</pub-id>--><pub-id pub-id-type="pmid">19462339</pub-id>
</element-citation></ref><ref id="ref62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maaskant</surname><given-names>JM</given-names></name><name><surname>Eskes</surname><given-names>A</given-names></name><name><surname>van Rijn-Bikker</surname><given-names>P</given-names></name><name><surname>Bosman</surname><given-names>D</given-names></name><name><surname>van Aalderen</surname><given-names>W</given-names></name><name><surname>Vermeulen</surname><given-names>H</given-names></name></person-group><article-title>High-alert medications for pediatric patients: an international modified Delphi study</article-title><source>Expert Opin Drug Saf</source><year>2013</year><month>11</month><day>10</day><volume>12</volume><issue>6</issue><fpage>805</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1517/14740338.2013.825247</pub-id><pub-id pub-id-type="medline">23931332</pub-id><pub-id pub-id-type="pmid">23931332</pub-id>
</element-citation></ref><ref id="ref63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pouliot</surname><given-names>A</given-names></name><name><surname>Vaillancourt</surname><given-names>R</given-names></name><name><surname>Stacey</surname><given-names>D</given-names></name><name><surname>Suter</surname><given-names>P</given-names></name></person-group><article-title>Defining and identifying concepts of medication literacy: an international perspective</article-title><source>Res Social Adm Pharm</source><year>2018</year><month>09</month><volume>14</volume><issue>9</issue><fpage>797</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1016/j.sapharm.2017.11.005</pub-id><pub-id pub-id-type="medline">29191647</pub-id><pub-id pub-id-type="pii">S1551-7411(17)30290-5</pub-id><pub-id pub-id-type="pmid">29191647</pub-id>
</element-citation></ref><ref id="ref64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penm</surname><given-names>J</given-names></name><name><surname>Vaillancourt</surname><given-names>R</given-names></name><name><surname>Pouliot</surname><given-names>A</given-names></name></person-group><article-title>Defining and identifying concepts of medication reconciliation: an international pharmacy perspective</article-title><source>Res Social Adm Pharm</source><year>2019</year><month>06</month><volume>15</volume><issue>6</issue><fpage>632</fpage><lpage>40</lpage><comment>
<ext-link xlink:href="https://doi.org/10.1016/j.sapharm.2018.07.020" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1016/j.sapharm.2018.07.020</pub-id><pub-id pub-id-type="medline">30100200</pub-id><pub-id pub-id-type="pii">S1551-7411(18)30294-8</pub-id><pub-id pub-id-type="pmid">30100200</pub-id>
</element-citation></ref><ref id="ref65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>KE</given-names></name><name><surname>Singleton</surname><given-names>JA</given-names></name><name><surname>Tippett</surname><given-names>V</given-names></name><name><surname>Nissen</surname><given-names>LM</given-names></name></person-group><article-title>Defining pharmacists' roles in disasters: a Delphi study</article-title><source>PLoS One</source><year>2019</year><month>12</month><day>26</day><volume>14</volume><issue>12</issue><fpage>e0227132</fpage><comment>
<ext-link xlink:href="https://dx.plos.org/10.1371/journal.pone.0227132" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1371/journal.pone.0227132</pub-id><pub-id pub-id-type="medline">31877194</pub-id><pub-id pub-id-type="pii">PONE-D-19-28283</pub-id><!--<pub-id pub-id-type="pmcid">PMC6932796</pub-id>--><pub-id pub-id-type="pmid">31877194</pub-id>
</element-citation></ref><ref id="ref66"><label>66</label><element-citation publication-type="webpage"><article-title>Delphi Method Software eDelphi</article-title><source>Metodix Ltd</source><date-in-citation content-type="access-date">2024-08-12</date-in-citation><comment>
<ext-link xlink:href="https://www.edelphi.org/" ext-link-type="uri">https://www.edelphi.org/</ext-link>
</comment></element-citation></ref><ref id="ref67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burns</surname><given-names>A</given-names></name></person-group><article-title>Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0)</article-title><source>J Am Pharm Assoc</source><year>2008</year><month>05</month><volume>48</volume><issue>3</issue><fpage>341</fpage><lpage>53</lpage><comment>
<ext-link xlink:href="https://doi.org/10.1331/japha.2008.08514" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1331/japha.2008.08514</pub-id></element-citation></ref><ref id="ref68"><label>68</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Clyne</surname><given-names>W</given-names></name><name><surname>Blenkinsopp</surname><given-names>A</given-names></name><name><surname>Seal</surname><given-names>R</given-names></name></person-group><article-title>A guide to medication review 2008</article-title><source>National Health Service</source><year>2008</year><date-in-citation content-type="access-date">2024-10-15</date-in-citation><comment>
<ext-link xlink:href="https://www.cff.org.br/userfiles/52%20-%20CLYNE%20W%20A%20guide%20to%20medication%20review%202008.pdf" ext-link-type="uri">https://www.cff.org.br/userfiles/52%20-%20CLYNE%20W%20A%20guide%20to%20medication%20review%202008.pdf</ext-link>
</comment></element-citation></ref><ref id="ref69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaMantia</surname><given-names>MA</given-names></name><name><surname>Scheunemann</surname><given-names>LP</given-names></name><name><surname>Viera</surname><given-names>AJ</given-names></name><name><surname>Busby-Whitehead</surname><given-names>J</given-names></name><name><surname>Hanson</surname><given-names>LC</given-names></name></person-group><article-title>Interventions to improve transitional care between nursing homes and hospitals: a systematic review</article-title><source>J Am Geriatr Soc</source><year>2010</year><month>04</month><volume>58</volume><issue>4</issue><fpage>777</fpage><lpage>82</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/20398162" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1111/j.1532-5415.2010.02776.x</pub-id><pub-id pub-id-type="medline">20398162</pub-id><pub-id pub-id-type="pii">JGS2776</pub-id><!--<pub-id pub-id-type="pmcid">PMC4407558</pub-id>--><pub-id pub-id-type="pmid">20398162</pub-id>
</element-citation></ref><ref id="ref70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loganathan</surname><given-names>M</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Franklin</surname><given-names>BD</given-names></name><name><surname>Bottle</surname><given-names>A</given-names></name><name><surname>Majeed</surname><given-names>A</given-names></name></person-group><article-title>Interventions to optimise prescribing in care homes: systematic review</article-title><source>Age Ageing</source><year>2011</year><month>03</month><volume>40</volume><issue>2</issue><fpage>150</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1093/ageing/afq161</pub-id><pub-id pub-id-type="medline">21262782</pub-id><pub-id pub-id-type="pii">afq161</pub-id><pub-id pub-id-type="pmid">21262782</pub-id>
</element-citation></ref><ref id="ref71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blenkinsopp</surname><given-names>A</given-names></name><name><surname>Bond</surname><given-names>C</given-names></name><name><surname>Raynor</surname><given-names>DK</given-names></name></person-group><article-title>Medication reviews</article-title><source>Br J Clin Pharmacol</source><year>2012</year><month>10</month><day>05</day><volume>74</volume><issue>4</issue><fpage>573</fpage><lpage>80</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/22607195" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1111/j.1365-2125.2012.04331.x</pub-id><pub-id pub-id-type="medline">22607195</pub-id><!--<pub-id pub-id-type="pmcid">PMC3477324</pub-id>--><pub-id pub-id-type="pmid">22607195</pub-id>
</element-citation></ref><ref id="ref72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwint</surname><given-names>HF</given-names></name><name><surname>Bermingham</surname><given-names>L</given-names></name><name><surname>Faber</surname><given-names>A</given-names></name><name><surname>Gussekloo</surname><given-names>J</given-names></name><name><surname>Bouvy</surname><given-names>ML</given-names></name></person-group><article-title>The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review</article-title><source>Drugs Aging</source><year>2013</year><month>02</month><day>16</day><volume>30</volume><issue>2</issue><fpage>91</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1007/s40266-012-0048-6</pub-id><pub-id pub-id-type="medline">23322285</pub-id><pub-id pub-id-type="pmid">23322285</pub-id>
</element-citation></ref><ref id="ref73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>SM</given-names></name><name><surname>Cadogan</surname><given-names>CA</given-names></name><name><surname>Kerse</surname><given-names>N</given-names></name><name><surname>Cardwell</surname><given-names>CR</given-names></name><name><surname>Bradley</surname><given-names>MC</given-names></name><name><surname>Ryan</surname><given-names>C</given-names></name><name><surname>Hughes</surname><given-names>C</given-names></name></person-group><article-title>Interventions to improve the appropriate use of polypharmacy for older people</article-title><source>Cochrane Database Syst Rev</source><year>2014</year><month>10</month><day>07</day><volume>10</volume><issue>10</issue><fpage>CD008165</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD008165.pub3</pub-id><pub-id pub-id-type="medline">25288041</pub-id></element-citation></ref><ref id="ref74"><label>74</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>National Institute for Health and Care Excellence</collab></person-group><article-title>Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes</article-title><year>2015</year><month>3</month><day>4</day><date-in-citation content-type="access-date">2024-05-26</date-in-citation><comment>
<ext-link xlink:href="https://nice.org.uk/guidance/ng5" ext-link-type="uri">https://nice.org.uk/guidance/ng5</ext-link>
</comment></element-citation></ref><ref id="ref75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>TF</given-names></name></person-group><article-title>Pharmacist-led home medicines review and residential medication management review: the Australian model</article-title><source>Drugs Aging</source><year>2016</year><month>03</month><day>9</day><volume>33</volume><issue>3</issue><fpage>199</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1007/s40266-016-0357-2</pub-id><pub-id pub-id-type="medline">26961696</pub-id><pub-id pub-id-type="pii">10.1007/s40266-016-0357-2</pub-id><pub-id pub-id-type="pmid">26961696</pub-id>
</element-citation></ref><ref id="ref76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jokanovic</surname><given-names>N</given-names></name><name><surname>Tan</surname><given-names>EC</given-names></name><name><surname>van den Bosch</surname><given-names>D</given-names></name><name><surname>Kirkpatrick</surname><given-names>CM</given-names></name><name><surname>Dooley</surname><given-names>MJ</given-names></name><name><surname>Bell</surname><given-names>JS</given-names></name></person-group><article-title>Clinical medication review in Australia: a systematic review</article-title><source>Res Social Adm Pharm</source><year>2016</year><month>05</month><volume>12</volume><issue>3</issue><fpage>384</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1016/j.sapharm.2015.06.007</pub-id><pub-id pub-id-type="medline">26250049</pub-id><pub-id pub-id-type="pii">S1551-7411(15)00124-2</pub-id><pub-id pub-id-type="pmid">26250049</pub-id>
</element-citation></ref><ref id="ref77"><label>77</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Kiiski</surname><given-names>A</given-names></name><name><surname>Kallio</surname><given-names>S</given-names></name><name><surname>Pohjanoksa-M&#x000e4;ntyl&#x000e4;</surname><given-names>M</given-names></name><name><surname>Kumpusalo-Vauhkonen</surname><given-names>A</given-names></name><name><surname>J&#x000e4;rvensivu</surname><given-names>T</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name><name><surname>M&#x000e4;ntyl&#x000e4;</surname><given-names>A</given-names></name></person-group><article-title>Reports and memorandums of the Ministry of Social Affairs and Health 19/2018</article-title><source>Rationalization of Pharmacotherapy for the Elderly as an Inter-Professional Collaboration. Systematic Review (in Finnish)</source><year>2018</year><date-in-citation content-type="access-date">2024-05-26</date-in-citation><comment>
<ext-link xlink:href="https://julkaisut.valtioneuvosto.fi/bitstream/handle/10024/74808/RAP-2016-12-iakkaiden-l%c3%a4%c3%a4kehoidon-j%c3%a4rkeist%c3%a4minen.pdf?sequence=1&#x00026;isAllowed=y" ext-link-type="uri">https://julkaisut.valtioneuvosto.fi/bitstream/handle/10024/74808/RAP-2016-12-iakkaiden-l%c3%a4%c3%a4kehoidon-j%c3%a4rkeist%c3%a4minen.pdf?sequence=1&#x00026;isAllowed=y</ext-link>
</comment></element-citation></ref><ref id="ref78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>P</given-names></name><name><surname>Cabral</surname><given-names>C</given-names></name><name><surname>McCahon</surname><given-names>D</given-names></name><name><surname>Guthrie</surname><given-names>B</given-names></name><name><surname>Ridd</surname><given-names>MJ</given-names></name></person-group><article-title>Efficiency versus thoroughness in medication review: a qualitative interview study in UK primary care</article-title><source>Br J Gen Pract</source><year>2019</year><month>02</month><day>11</day><volume>69</volume><issue>680</issue><fpage>e190</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.3399/bjgp19x701321</pub-id><pub-id pub-id-type="pmid">30745357</pub-id>
</element-citation></ref><ref id="ref79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>O</given-names></name><name><surname>Cheong</surname><given-names>VL</given-names></name><name><surname>Dhaliwall</surname><given-names>S</given-names></name><name><surname>Eislage</surname><given-names>K</given-names></name><name><surname>Erzkamp</surname><given-names>S</given-names></name><name><surname>Jorgenson</surname><given-names>D</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>F</given-names></name><name><surname>Luetsch</surname><given-names>K</given-names></name></person-group><article-title>Standards in medication review: an international perspective</article-title><source>Can Pharm J (Ott)</source><year>2020</year><month>07</month><day>14</day><volume>153</volume><issue>4</issue><fpage>215</fpage><lpage>23</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/33193923" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1177/1715163520929665</pub-id><pub-id pub-id-type="medline">33193923</pub-id><pub-id pub-id-type="pii">10.1177_1715163520929665</pub-id><!--<pub-id pub-id-type="pmcid">PMC7605065</pub-id>--><pub-id pub-id-type="pmid">33193923</pub-id>
</element-citation></ref><ref id="ref80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lias</surname><given-names>N</given-names></name><name><surname>Lindholm</surname><given-names>T</given-names></name><name><surname>Pohjanoksa-M&#x000e4;ntyl&#x000e4;</surname><given-names>M</given-names></name><name><surname>Westerholm</surname><given-names>A</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name></person-group><article-title>Developing and piloting a self-assessment tool for medication review competence of practicing pharmacists based on nationally set competence criteria</article-title><source>BMC Health Serv Res</source><year>2021</year><month>11</month><day>25</day><volume>21</volume><issue>1</issue><fpage>1274</fpage><comment>
<ext-link xlink:href="https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-021-07291-6" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1186/s12913-021-07291-6</pub-id><pub-id pub-id-type="medline">34823529</pub-id><pub-id pub-id-type="pii">10.1186/s12913-021-07291-6</pub-id><!--<pub-id pub-id-type="pmcid">PMC8620234</pub-id>--><pub-id pub-id-type="pmid">34823529</pub-id>
</element-citation></ref><ref id="ref81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanlon</surname><given-names>JT</given-names></name><name><surname>Schmader</surname><given-names>KE</given-names></name><name><surname>Samsa</surname><given-names>GP</given-names></name><name><surname>Weinberger</surname><given-names>M</given-names></name><name><surname>Uttech</surname><given-names>KM</given-names></name><name><surname>Lewis</surname><given-names>IK</given-names></name><name><surname>Cohen</surname><given-names>HJ</given-names></name><name><surname>Feussner</surname><given-names>JR</given-names></name></person-group><article-title>A method for assessing drug therapy appropriateness</article-title><source>J Clin Epidemiol</source><year>1992</year><month>10</month><volume>45</volume><issue>10</issue><fpage>1045</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/0895-4356(92)90144-c</pub-id><pub-id pub-id-type="medline">1474400</pub-id><pub-id pub-id-type="pii">0895-4356(92)90144-C</pub-id><pub-id pub-id-type="pmid">1474400</pub-id>
</element-citation></ref><ref id="ref82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>By the 2019 American Geriatrics Society Beers Criteria&#x000ae; Update Expert Panel</collab></person-group><article-title>American Geriatrics Society 2019 Updated AGS Beers Criteria&#x000ae; for potentially inappropriate medication use in older adults</article-title><source>J Am Geriatr Soc</source><year>2019</year><month>04</month><volume>67</volume><issue>4</issue><fpage>674</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1111/jgs.15767</pub-id><pub-id pub-id-type="medline">30693946</pub-id><pub-id pub-id-type="pmid">30693946</pub-id>
</element-citation></ref><ref id="ref83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strand</surname><given-names>LM</given-names></name><name><surname>Morley</surname><given-names>PC</given-names></name><name><surname>Cipolle</surname><given-names>RJ</given-names></name><name><surname>Ramsey</surname><given-names>R</given-names></name><name><surname>Lamsam</surname><given-names>GD</given-names></name></person-group><article-title>Drug-related problems: their structure and function</article-title><source>DICP</source><year>1990</year><month>11</month><day>01</day><volume>24</volume><issue>11</issue><fpage>1093</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1177/106002809002401114</pub-id><pub-id pub-id-type="medline">2275235</pub-id><pub-id pub-id-type="pmid">2275235</pub-id>
</element-citation></ref><ref id="ref84"><label>84</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cipolle</surname><given-names>RJ</given-names></name><name><surname>Strand</surname><given-names>LM</given-names></name><name><surname>Morley</surname><given-names>PC</given-names></name></person-group><source>Pharmaceutical Care Practice: The Clinician's Guide, Second Edition</source><year>2004</year><publisher-loc>New York, NY</publisher-loc><publisher-name>McGraw-Hill Education</publisher-name></element-citation></ref><ref id="ref85"><label>85</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cipolle</surname><given-names>RJ</given-names></name><name><surname>Strand</surname><given-names>LM</given-names></name><name><surname>Morley</surname><given-names>PC</given-names></name></person-group><source>Pharmaceutical Care Practice: The Patient Centered Approach to Medication Management. 3rd Edition</source><year>2012</year><publisher-loc>New York, NY</publisher-loc><publisher-name>McGraw-Hill Education</publisher-name></element-citation></ref><ref id="ref86"><label>86</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Pharmaceutical Care Network Europe Association</collab></person-group><article-title>Classification for drug related problems</article-title><year>2019</year><date-in-citation content-type="access-date">2024-05-05</date-in-citation><comment>
<ext-link xlink:href="https://www.pcne.org/upload/files/410_PCNE_classification_V9-0m.pdf" ext-link-type="uri">https://www.pcne.org/upload/files/410_PCNE_classification_V9-0m.pdf</ext-link>
</comment></element-citation></ref><ref id="ref87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanninen</surname><given-names>JC</given-names></name><name><surname>Puustinen</surname><given-names>J</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name><name><surname>Kautiainen</surname><given-names>H</given-names></name><name><surname>Koivisto</surname><given-names>AL</given-names></name><name><surname>Hietasalo</surname><given-names>P</given-names></name><name><surname>Heikkil&#x000e4;</surname><given-names>AM</given-names></name><name><surname>Kunvik</surname><given-names>S</given-names></name><name><surname>Toivo</surname><given-names>T</given-names></name><name><surname>Dimitrow</surname><given-names>M</given-names></name><name><surname>Bergman</surname><given-names>J</given-names></name><name><surname>Holm</surname><given-names>A</given-names></name></person-group><article-title>Self-assessed medication risk factors as part of comprehensive health screening in home-dwelling older adults</article-title><source>Health Sci Rep</source><year>2023</year><month>04</month><day>13</day><volume>6</volume><issue>4</issue><fpage>e1196</fpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/37064318" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1002/hsr2.1196</pub-id><pub-id pub-id-type="medline">37064318</pub-id><pub-id pub-id-type="pii">HSR21196</pub-id><!--<pub-id pub-id-type="pmcid">PMC10101948</pub-id>--><pub-id pub-id-type="pmid">37064318</pub-id>
</element-citation></ref><ref id="ref88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranganathan</surname><given-names>P</given-names></name><name><surname>Caduff</surname><given-names>C</given-names></name><name><surname>Frampton</surname><given-names>CM</given-names></name></person-group><article-title>Designing and validating a research questionnaire - part 2</article-title><source>Perspect Clin Res</source><year>2024</year><volume>15</volume><issue>1</issue><fpage>42</fpage><lpage>5</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/38282630" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.4103/picr.picr_318_23</pub-id><pub-id pub-id-type="medline">38282630</pub-id><pub-id pub-id-type="pii">PCR-15-42</pub-id><!--<pub-id pub-id-type="pmcid">PMC10810057</pub-id>--><pub-id pub-id-type="pmid">38282630</pub-id>
</element-citation></ref><ref id="ref89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jormanainen</surname><given-names>V</given-names></name><name><surname>Lindgren</surname><given-names>M</given-names></name><name><surname>Keskim&#x000e4;ki</surname><given-names>I</given-names></name><name><surname>Kaila</surname><given-names>M</given-names></name></person-group><article-title>Use of My Kanta in Finland 2010-2022</article-title><source>Stud Health Technol Inform</source><year>2023</year><month>06</month><day>29</day><volume>305</volume><fpage>448</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.3233/SHTI230528</pub-id><pub-id pub-id-type="medline">37387062</pub-id><pub-id pub-id-type="pii">SHTI230528</pub-id><pub-id pub-id-type="pmid">37387062</pub-id>
</element-citation></ref><ref id="ref90"><label>90</label><element-citation publication-type="webpage"><article-title>MyKanta</article-title><source>Kanta</source><date-in-citation content-type="access-date">2024-09-07</date-in-citation><comment>
<ext-link xlink:href="https://www.kanta.fi/en/my-kanta-pages" ext-link-type="uri">https://www.kanta.fi/en/my-kanta-pages</ext-link>
</comment></element-citation></ref><ref id="ref91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elo</surname><given-names>S</given-names></name><name><surname>Kyng&#x000e4;s</surname><given-names>H</given-names></name></person-group><article-title>The qualitative content analysis process</article-title><source>J Adv Nurs</source><year>2008</year><month>04</month><volume>62</volume><issue>1</issue><fpage>107</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2648.2007.04569.x</pub-id><pub-id pub-id-type="medline">18352969</pub-id><pub-id pub-id-type="pii">JAN4569</pub-id><pub-id pub-id-type="pmid">18352969</pub-id>
</element-citation></ref><ref id="ref92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diamond</surname><given-names>IR</given-names></name><name><surname>Grant</surname><given-names>RC</given-names></name><name><surname>Feldman</surname><given-names>BM</given-names></name><name><surname>Pencharz</surname><given-names>PB</given-names></name><name><surname>Ling</surname><given-names>SC</given-names></name><name><surname>Moore</surname><given-names>AM</given-names></name><name><surname>Wales</surname><given-names>PW</given-names></name></person-group><article-title>Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies</article-title><source>J Clin Epidemiol</source><year>2014</year><month>04</month><volume>67</volume><issue>4</issue><fpage>401</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2013.12.002</pub-id><pub-id pub-id-type="medline">24581294</pub-id><pub-id pub-id-type="pii">S0895-4356(13)00507-6</pub-id><pub-id pub-id-type="pmid">24581294</pub-id>
</element-citation></ref><ref id="ref93"><label>93</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Finnish Advisory Board on Research Integrity</collab></person-group><article-title>Responsible conduct of research and procedures for handling allegations of misconduct in Finland</article-title><year>2012</year><date-in-citation content-type="access-date">2024-05-15</date-in-citation><comment>
<ext-link xlink:href="http://www.tenk.fi/sites/tenk.fi/files/HTK_ohje_2012.pdf" ext-link-type="uri">http://www.tenk.fi/sites/tenk.fi/files/HTK_ohje_2012.pdf</ext-link>
</comment></element-citation></ref><ref id="ref94"><label>94</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Finnish National Board on Research Integrity TENK</collab></person-group><article-title>The ethical principles of research with human participants and ethical review in the human sciences in Finland</article-title><source>Finnish National Board on Research Integrity TEKN Guidelines</source><year>2019</year><date-in-citation content-type="access-date">2024-05-15</date-in-citation><comment>
<ext-link xlink:href="https://tenk.fi/sites/default/files/2021-01/Ethical_review_in_human_sciences_2020.pdf" ext-link-type="uri">https://tenk.fi/sites/default/files/2021-01/Ethical_review_in_human_sciences_2020.pdf</ext-link>
</comment></element-citation></ref><ref id="ref95"><label>95</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Office of a Data Protection Ombudsman</collab></person-group><article-title>Scientific research and data protection</article-title><year>2020</year><date-in-citation content-type="access-date">2024-05-15</date-in-citation><comment>
<ext-link xlink:href="https://tietosuoja.fi/en/scientific-research-and-data-protection" ext-link-type="uri">https://tietosuoja.fi/en/scientific-research-and-data-protection</ext-link>
</comment></element-citation></ref><ref id="ref96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elinder</surname><given-names>CG</given-names></name><name><surname>B&#x000e1;r&#x000e1;ny</surname><given-names>P</given-names></name><name><surname>Heimb&#x000fc;rger</surname><given-names>O</given-names></name></person-group><article-title>The use of estimated glomerular filtration rate for dose adjustment of medications in the elderly</article-title><source>Drugs Aging</source><year>2014</year><month>07</month><day>6</day><volume>31</volume><issue>7</issue><fpage>493</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s40266-014-0187-z</pub-id><pub-id pub-id-type="medline">24902935</pub-id><pub-id pub-id-type="pmid">24902935</pub-id>
</element-citation></ref><ref id="ref97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000f6;rks</surname><given-names>M</given-names></name><name><surname>Allers</surname><given-names>K</given-names></name><name><surname>Schmiemann</surname><given-names>G</given-names></name><name><surname>Herget-Rosenthal</surname><given-names>S</given-names></name><name><surname>Hoffmann</surname><given-names>F</given-names></name></person-group><article-title>Inappropriate medication in non-hospitalized patients with renal insufficiency: a systematic review</article-title><source>J Am Geriatr Soc</source><year>2017</year><month>04</month><day>27</day><volume>65</volume><issue>4</issue><fpage>853</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1111/jgs.14809</pub-id><pub-id pub-id-type="medline">28240771</pub-id><pub-id pub-id-type="pmid">28240771</pub-id>
</element-citation></ref><ref id="ref98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesfaye</surname><given-names>WH</given-names></name><name><surname>Castelino</surname><given-names>RL</given-names></name><name><surname>Wimmer</surname><given-names>BC</given-names></name><name><surname>Zaidi</surname><given-names>ST</given-names></name></person-group><article-title>Inappropriate prescribing in chronic kidney disease: a systematic review of prevalence, associated clinical outcomes and impact of interventions</article-title><source>Int J Clin Pract</source><year>2017</year><month>07</month><day>23</day><volume>71</volume><issue>7</issue><fpage>e12960</fpage><pub-id pub-id-type="doi">10.1111/ijcp.12960</pub-id><pub-id pub-id-type="medline">28544106</pub-id></element-citation></ref><ref id="ref99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>J</given-names></name><name><surname>Hazzan</surname><given-names>A</given-names></name><name><surname>Mathew</surname><given-names>AT</given-names></name><name><surname>Sakhiya</surname><given-names>V</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Halinski</surname><given-names>C</given-names></name><name><surname>Fishbane</surname><given-names>S</given-names></name></person-group><article-title>Medication discrepancies in late-stage chronic kidney disease</article-title><source>Clin Kidney J</source><year>2018</year><month>08</month><volume>11</volume><issue>4</issue><fpage>507</fpage><lpage>12</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/30087772" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1093/ckj/sfx135</pub-id><pub-id pub-id-type="medline">30087772</pub-id><pub-id pub-id-type="pii">sfx135</pub-id><!--<pub-id pub-id-type="pmcid">PMC6070123</pub-id>--><pub-id pub-id-type="pmid">30087772</pub-id>
</element-citation></ref><ref id="ref100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koskela</surname><given-names>T</given-names></name><name><surname>Sandstr&#x000f6;m</surname><given-names>S</given-names></name><name><surname>M&#x000e4;kinen</surname><given-names>J</given-names></name><name><surname>Liira</surname><given-names>H</given-names></name></person-group><article-title>User perspectives on an electronic decision-support tool performing comprehensive medication reviews - a focus group study with physicians and nurses</article-title><source>BMC Med Inform Decis Mak</source><year>2016</year><month>01</month><day>22</day><volume>16</volume><issue>1</issue><fpage>6</fpage><comment>
<ext-link xlink:href="https://bmcmedinformdecismak.biomedcentral.com/articles/10.1186/s12911-016-0245-z" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1186/s12911-016-0245-z</pub-id><pub-id pub-id-type="medline">26801630</pub-id><pub-id pub-id-type="pii">10.1186/s12911-016-0245-z</pub-id><!--<pub-id pub-id-type="pmcid">PMC4724080</pub-id>--><pub-id pub-id-type="pmid">26801630</pub-id>
</element-citation></ref><ref id="ref101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alagiakrishnan</surname><given-names>K</given-names></name><name><surname>Wilson</surname><given-names>P</given-names></name><name><surname>Sadowski</surname><given-names>C</given-names></name><name><surname>Rolfson</surname><given-names>D</given-names></name><name><surname>Ballerman</surname><given-names>M</given-names></name><name><surname>Ausford</surname><given-names>A</given-names></name><name><surname>Vermeer</surname><given-names>K</given-names></name><name><surname>Mohindra</surname><given-names>K</given-names></name><name><surname>Romney</surname><given-names>J</given-names></name><name><surname>Hayward</surname><given-names>R</given-names></name></person-group><article-title>Physicians&#x02019; use of computerized clinical decision supports to improve medication management in the elderly &#x02013; the Seniors Medication Alert and Review Technology intervention</article-title><source>Clin Interv Aging</source><year>2016</year><month>01</month><volume>11</volume><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.2147/cia.s94126</pub-id><pub-id pub-id-type="pmid">26869776</pub-id>
</element-citation></ref><ref id="ref102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modig</surname><given-names>S</given-names></name><name><surname>Lannering</surname><given-names>C</given-names></name><name><surname>Ostgren</surname><given-names>CJ</given-names></name><name><surname>M&#x000f6;lstad</surname><given-names>S</given-names></name><name><surname>Midl&#x000f6;v</surname><given-names>P</given-names></name></person-group><article-title>The assessment of renal function in relation to the use of drugs in elderly in nursing homes; a cohort study</article-title><source>BMC Geriatr</source><year>2011</year><month>01</month><day>11</day><volume>11</volume><issue>1</issue><fpage>1</fpage><comment>
<ext-link xlink:href="https://bmcgeriatr.biomedcentral.com/articles/10.1186/1471-2318-11-1" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1186/1471-2318-11-1</pub-id><pub-id pub-id-type="medline">21223578</pub-id><pub-id pub-id-type="pii">1471-2318-11-1</pub-id><!--<pub-id pub-id-type="pmcid">PMC3025849</pub-id>--><pub-id pub-id-type="pmid">21223578</pub-id>
</element-citation></ref><ref id="ref103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallio</surname><given-names>S</given-names></name><name><surname>Eskola</surname><given-names>T</given-names></name><name><surname>Pohjanoksa-M&#x000e4;ntyl&#x000e4;</surname><given-names>M</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name></person-group><article-title>Medication risk management in routine dispensing in community pharmacies</article-title><source>Int J Environ Res Public Health</source><year>2020</year><month>11</month><day>05</day><volume>17</volume><issue>21</issue><fpage>8186</fpage><comment>
<ext-link xlink:href="https://www.mdpi.com/resolver?pii=ijerph17218186" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.3390/ijerph17218186</pub-id><pub-id pub-id-type="medline">33167543</pub-id><pub-id pub-id-type="pii">ijerph17218186</pub-id><!--<pub-id pub-id-type="pmcid">PMC7663945</pub-id>--><pub-id pub-id-type="pmid">33167543</pub-id>
</element-citation></ref><ref id="ref104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellinger</surname><given-names>LK</given-names></name><name><surname>Bursua</surname><given-names>A</given-names></name><name><surname>Galanter</surname><given-names>W</given-names></name><name><surname>Schiff</surname><given-names>GD</given-names></name><name><surname>Lambert</surname><given-names>BL</given-names></name></person-group><article-title>Empowering pharmacists with data: steps toward proactive medication safety and quality improvement</article-title><source>J Am Coll Clin Pharm</source><year>2024</year><month>06</month><day>27</day><volume>7</volume><issue>8</issue><fpage>824</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1002/jac5.2002</pub-id></element-citation></ref><ref id="ref105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bush</surname><given-names>RA</given-names></name><name><surname>Kuelbs</surname><given-names>C</given-names></name><name><surname>Ryu</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Chiang</surname><given-names>G</given-names></name></person-group><article-title>Structured data entry in the electronic medical record: perspectives of pediatric specialty physicians and surgeons</article-title><source>J Med Syst</source><year>2017</year><month>05</month><day>21</day><volume>41</volume><issue>5</issue><fpage>75</fpage><pub-id pub-id-type="doi">10.1007/s10916-017-0716-5</pub-id><pub-id pub-id-type="medline">28324321</pub-id><pub-id pub-id-type="pii">10.1007/s10916-017-0716-5</pub-id><!--<pub-id pub-id-type="pmcid">PMC5510605</pub-id>--><pub-id pub-id-type="pmid">28324321</pub-id>
</element-citation></ref><ref id="ref106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>SM</given-names></name><name><surname>Khan</surname><given-names>RA</given-names></name></person-group><article-title>Secondary use of electronic health record: opportunities and challenges</article-title><source>IEEE Access</source><year>2020</year><volume>8</volume><fpage>136947</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1109/access.2020.3011099</pub-id></element-citation></ref><ref id="ref107"><label>107</label><element-citation publication-type="webpage"><article-title>LOINC</article-title><source>Regenstrief Institute</source><date-in-citation content-type="access-date">2025-03-01</date-in-citation><comment>
<ext-link xlink:href="https://loinc.org/" ext-link-type="uri">https://loinc.org/</ext-link>
</comment></element-citation></ref><ref id="ref108"><label>108</label><element-citation publication-type="webpage"><article-title>RxNORM</article-title><source>National Institutes of Health National Library of Medicine</source><date-in-citation content-type="access-date">2025-02-28</date-in-citation><comment>
<ext-link xlink:href="https://www.nlm.nih.gov/research/umls/rxnorm/index.html" ext-link-type="uri">https://www.nlm.nih.gov/research/umls/rxnorm/index.html</ext-link>
</comment></element-citation></ref><ref id="ref109"><label>109</label><element-citation publication-type="webpage"><article-title>Welcome to FHIR&#x000ae;</article-title><source>HL7&#x000ae; FHIR&#x000ae; Foundation</source><date-in-citation content-type="access-date">2025-03-02</date-in-citation><comment>
<ext-link xlink:href="https://www.hl7.org/fhir/index.html" ext-link-type="uri">https://www.hl7.org/fhir/index.html</ext-link>
</comment></element-citation></ref><ref id="ref110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salgado</surname><given-names>TM</given-names></name><name><surname>Correr</surname><given-names>CJ</given-names></name><name><surname>Moles</surname><given-names>R</given-names></name><name><surname>Benrimoj</surname><given-names>SI</given-names></name><name><surname>Fernandez-Llimos</surname><given-names>F</given-names></name></person-group><article-title>Assessing the implementability of clinical pharmacist interventions in patients with chronic kidney disease: an analysis of systematic reviews</article-title><source>Ann Pharmacother</source><year>2013</year><month>11</month><day>27</day><volume>47</volume><issue>11</issue><fpage>1498</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1177/1060028013501802</pub-id><pub-id pub-id-type="medline">24259596</pub-id><pub-id pub-id-type="pii">1060028013501802</pub-id><pub-id pub-id-type="pmid">24259596</pub-id>
</element-citation></ref><ref id="ref111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pourrat</surname><given-names>X</given-names></name><name><surname>Sipert</surname><given-names>AS</given-names></name><name><surname>Gatault</surname><given-names>P</given-names></name><name><surname>Sautenet</surname><given-names>B</given-names></name><name><surname>Hay</surname><given-names>N</given-names></name><name><surname>Guinard</surname><given-names>F</given-names></name><name><surname>Guegan</surname><given-names>F</given-names></name><name><surname>Halimi</surname><given-names>JM</given-names></name></person-group><article-title>Community pharmacist intervention in patients with renal impairment</article-title><source>Int J Clin Pharm</source><year>2015</year><month>12</month><day>18</day><volume>37</volume><issue>6</issue><fpage>1172</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s11096-015-0182-4</pub-id><pub-id pub-id-type="medline">26385098</pub-id><pub-id pub-id-type="pii">10.1007/s11096-015-0182-4</pub-id><pub-id pub-id-type="pmid">26385098</pub-id>
</element-citation></ref><ref id="ref112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mongaret</surname><given-names>C</given-names></name><name><surname>Aubert</surname><given-names>L</given-names></name><name><surname>Lestrille</surname><given-names>A</given-names></name><name><surname>Albaut</surname><given-names>V</given-names></name><name><surname>Kreit</surname><given-names>P</given-names></name><name><surname>Herlem</surname><given-names>E</given-names></name><name><surname>Noel</surname><given-names>N</given-names></name><name><surname>Tour&#x000e9;</surname><given-names>F</given-names></name><name><surname>Lallier</surname><given-names>F</given-names></name><name><surname>Slimano</surname><given-names>F</given-names></name></person-group><article-title>The role of community pharmacists in the detection of clinically relevant drug-related problems in chronic kidney disease patients</article-title><source>Pharmacy (Basel)</source><year>2020</year><month>05</month><day>22</day><volume>8</volume><issue>2</issue><fpage>89</fpage><comment>
<ext-link xlink:href="https://www.mdpi.com/resolver?pii=pharmacy8020089" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.3390/pharmacy8020089</pub-id><pub-id pub-id-type="medline">32456115</pub-id><pub-id pub-id-type="pii">pharmacy8020089</pub-id><!--<pub-id pub-id-type="pmcid">PMC7355920</pub-id>--><pub-id pub-id-type="pmid">32456115</pub-id>
</element-citation></ref><ref id="ref113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Maidment</surname><given-names>I</given-names></name><name><surname>Matthews</surname><given-names>F</given-names></name><name><surname>Robinson</surname><given-names>L</given-names></name><name><surname>Brayne</surname><given-names>C</given-names></name><collab>Medical Research Council Cognitive Function and Ageing Study</collab></person-group><article-title>Medication usage change in older people (65+) in England over 20 years: findings from CFAS I and CFAS II</article-title><source>Age Ageing</source><year>2018</year><month>03</month><day>01</day><volume>47</volume><issue>2</issue><fpage>220</fpage><lpage>5</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/29036509" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1093/ageing/afx158</pub-id><pub-id pub-id-type="medline">29036509</pub-id><pub-id pub-id-type="pii">4237359</pub-id><!--<pub-id pub-id-type="pmcid">PMC6037294</pub-id>--><pub-id pub-id-type="pmid">29036509</pub-id>
</element-citation></ref><ref id="ref114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>EH</given-names></name><name><surname>Pan</surname><given-names>S</given-names></name><name><surname>Yap</surname><given-names>AG</given-names></name><name><surname>Reveles</surname><given-names>KR</given-names></name><name><surname>Bhakta</surname><given-names>K</given-names></name></person-group><article-title>Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016</article-title><source>PLoS One</source><year>2021</year><month>8</month><day>3</day><volume>16</volume><issue>8</issue><fpage>e0255642</fpage><comment>
<ext-link xlink:href="https://dx.plos.org/10.1371/journal.pone.0255642" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1371/journal.pone.0255642</pub-id><pub-id pub-id-type="medline">34343225</pub-id><pub-id pub-id-type="pii">PONE-D-21-10322</pub-id><!--<pub-id pub-id-type="pmcid">PMC8330900</pub-id>--><pub-id pub-id-type="pmid">34343225</pub-id>
</element-citation></ref><ref id="ref115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delara</surname><given-names>M</given-names></name><name><surname>Murray</surname><given-names>L</given-names></name><name><surname>Jafari</surname><given-names>B</given-names></name><name><surname>Bahji</surname><given-names>A</given-names></name><name><surname>Goodarzi</surname><given-names>Z</given-names></name><name><surname>Kirkham</surname><given-names>J</given-names></name><name><surname>Chowdhury</surname><given-names>M</given-names></name><name><surname>Seitz</surname><given-names>DP</given-names></name></person-group><article-title>Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis</article-title><source>BMC Geriatr</source><year>2022</year><month>07</month><day>19</day><volume>22</volume><issue>1</issue><fpage>601</fpage><comment>
<ext-link xlink:href="https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-022-03279-x" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1186/s12877-022-03279-x</pub-id><pub-id pub-id-type="medline">35854209</pub-id><pub-id pub-id-type="pii">10.1186/s12877-022-03279-x</pub-id><!--<pub-id pub-id-type="pmcid">PMC9297624</pub-id>--><pub-id pub-id-type="pmid">35854209</pub-id>
</element-citation></ref><ref id="ref116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarn</surname><given-names>DM</given-names></name><name><surname>Mattimore</surname><given-names>TJ</given-names></name><name><surname>Bell</surname><given-names>DS</given-names></name><name><surname>Kravitz</surname><given-names>RL</given-names></name><name><surname>Wenger</surname><given-names>NS</given-names></name></person-group><article-title>Provider views about responsibility for medication adherence and content of physician-older patient discussions</article-title><source>J Am Geriatr Soc</source><year>2012</year><month>06</month><volume>60</volume><issue>6</issue><fpage>1019</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1111/j.1532-5415.2012.03969.x</pub-id><pub-id pub-id-type="medline">22646818</pub-id><!--<pub-id pub-id-type="pmcid">PMC3381510</pub-id>--><pub-id pub-id-type="pmid">22646818</pub-id>
</element-citation></ref><ref id="ref117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kjeldsen</surname><given-names>LJ</given-names></name><name><surname>Nielsen</surname><given-names>TR</given-names></name><name><surname>Olesen</surname><given-names>C</given-names></name></person-group><article-title>The challenges of outcome research</article-title><source>Int J Clin Pharm</source><year>2016</year><month>06</month><day>2</day><volume>38</volume><issue>3</issue><fpage>705</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s11096-016-0293-6</pub-id><pub-id pub-id-type="medline">27039091</pub-id><pub-id pub-id-type="pii">10.1007/s11096-016-0293-6</pub-id><pub-id pub-id-type="pmid">27039091</pub-id>
</element-citation></ref><ref id="ref118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berra</surname><given-names>E</given-names></name><name><surname>Azizi</surname><given-names>M</given-names></name><name><surname>Capron</surname><given-names>A</given-names></name><name><surname>H&#x000f8;ieggen</surname><given-names>A</given-names></name><name><surname>Rabbia</surname><given-names>F</given-names></name><name><surname>Kjeldsen</surname><given-names>SE</given-names></name><name><surname>Staessen</surname><given-names>JA</given-names></name><name><surname>Wallemacq</surname><given-names>P</given-names></name><name><surname>Persu</surname><given-names>A</given-names></name></person-group><article-title>Evaluation of adherence should become an integral part of assessment of patients with apparently treatment-resistant hypertension</article-title><source>Hypertension</source><year>2016</year><month>08</month><volume>68</volume><issue>2</issue><fpage>297</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1161/hypertensionaha.116.07464</pub-id><pub-id pub-id-type="pmid">27296995</pub-id>
</element-citation></ref><ref id="ref119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kek&#x000e4;le</surname><given-names>M</given-names></name><name><surname>Talvensaari</surname><given-names>K</given-names></name><name><surname>Koskenvesa</surname><given-names>P</given-names></name><name><surname>Porkka</surname><given-names>K</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name></person-group><article-title>Chronic myeloid leukemia patients' adherence to peroral tyrosine kinase inhibitors compared with adherence as estimated by their physicians</article-title><source>Patient Prefer Adherence</source><year>2014</year><volume>8</volume><fpage>1619</fpage><lpage>27</lpage><comment>
<ext-link xlink:href="https://www.tandfonline.com/doi/abs/10.2147/PPA.S70712?url_ver=Z39.88-2003&#x00026;rfr_id=ori:rid:crossref.org&#x00026;rfr_dat=cr_pub0pubmed" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.2147/PPA.S70712</pub-id><pub-id pub-id-type="medline">25473270</pub-id><pub-id pub-id-type="pii">ppa-8-1619</pub-id><!--<pub-id pub-id-type="pmcid">PMC4246993</pub-id>--><pub-id pub-id-type="pmid">25473270</pub-id>
</element-citation></ref><ref id="ref120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieuwlaat</surname><given-names>R</given-names></name><name><surname>Wilczynski</surname><given-names>N</given-names></name><name><surname>Navarro</surname><given-names>T</given-names></name><name><surname>Hobson</surname><given-names>N</given-names></name><name><surname>Jeffery</surname><given-names>R</given-names></name><name><surname>Keepanasseril</surname><given-names>A</given-names></name><name><surname>Agoritsas</surname><given-names>T</given-names></name><name><surname>Mistry</surname><given-names>N</given-names></name><name><surname>Iorio</surname><given-names>A</given-names></name><name><surname>Jack</surname><given-names>S</given-names></name><name><surname>Sivaramalingam</surname><given-names>B</given-names></name><name><surname>Iserman</surname><given-names>E</given-names></name><name><surname>Mustafa</surname><given-names>RA</given-names></name><name><surname>Jedraszewski</surname><given-names>D</given-names></name><name><surname>Cotoi</surname><given-names>C</given-names></name><name><surname>Haynes</surname><given-names>RB</given-names></name></person-group><article-title>Interventions for enhancing medication adherence</article-title><source>Cochrane Database Syst Rev</source><year>2014</year><month>11</month><day>20</day><volume>2014</volume><issue>11</issue><fpage>CD000011</fpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/25412402" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1002/14651858.CD000011.pub4</pub-id><pub-id pub-id-type="medline">25412402</pub-id><!--<pub-id pub-id-type="pmcid">PMC7263418</pub-id>--><pub-id pub-id-type="pmid">25412402</pub-id>
</element-citation></ref><ref id="ref121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>WY</given-names></name><name><surname>Fresco</surname><given-names>P</given-names></name></person-group><article-title>Medication adherence measures: an overview</article-title><source>Biomed Res Int</source><year>2015</year><volume>2015</volume><fpage>217047</fpage><comment>
<ext-link xlink:href="https://doi.org/10.1155/2015/217047" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1155/2015/217047</pub-id><pub-id pub-id-type="medline">26539470</pub-id><!--<pub-id pub-id-type="pmcid">PMC4619779</pub-id>--><pub-id pub-id-type="pmid">26539470</pub-id>
</element-citation></ref><ref id="ref122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bokhour</surname><given-names>BG</given-names></name><name><surname>Berlowitz</surname><given-names>DR</given-names></name><name><surname>Long</surname><given-names>JA</given-names></name><name><surname>Kressin</surname><given-names>NR</given-names></name></person-group><article-title>How do providers assess antihypertensive medication adherence in medical encounters?</article-title><source>J Gen Intern Med</source><year>2006</year><month>06</month><volume>21</volume><issue>6</issue><fpage>577</fpage><lpage>83</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/16808739" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1111/j.1525-1497.2006.00397.x</pub-id><pub-id pub-id-type="medline">16808739</pub-id><pub-id pub-id-type="pii">JGI397</pub-id><!--<pub-id pub-id-type="pmcid">PMC1924615</pub-id>--><pub-id pub-id-type="pmid">16808739</pub-id>
</element-citation></ref><ref id="ref123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtis</surname><given-names>JR</given-names></name><name><surname>Cai</surname><given-names>Q</given-names></name><name><surname>Wade</surname><given-names>SW</given-names></name><name><surname>Stolshek</surname><given-names>BS</given-names></name><name><surname>Adams</surname><given-names>JL</given-names></name><name><surname>Balasubramanian</surname><given-names>A</given-names></name><name><surname>Viswanathan</surname><given-names>HN</given-names></name><name><surname>Kallich</surname><given-names>JD</given-names></name></person-group><article-title>Osteoporosis medication adherence: physician perceptions vs. patients' utilization</article-title><source>Bone</source><year>2013</year><month>07</month><volume>55</volume><issue>1</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2013.03.003</pub-id><pub-id pub-id-type="pmid">23502042</pub-id>
</element-citation></ref><ref id="ref124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heeb</surname><given-names>RM</given-names></name><name><surname>Kreeuzberg</surname><given-names>V</given-names></name><name><surname>Grossmann</surname><given-names>V</given-names></name></person-group><article-title>Physicians' assessment of medication adherence: a systematic review</article-title><source>J Pharm Care Health Sys</source><year>2019</year><volume>06</volume><issue>01</issue><pub-id pub-id-type="doi">10.4172/2376-0419.1000202</pub-id></element-citation></ref><ref id="ref125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>VD</given-names></name><name><surname>Vo</surname><given-names>TM</given-names></name><name><surname>Vo</surname><given-names>QL</given-names></name><name><surname>Nguyen</surname><given-names>MT</given-names></name><name><surname>Nguyen</surname><given-names>MC</given-names></name><name><surname>Dewey</surname><given-names>RS</given-names></name><name><surname>Nguyen</surname><given-names>TH</given-names></name></person-group><article-title>Behavioral factors associated with medication adherence among hypertensive patients using the theoretical domains framework</article-title><source>Explor Res Clin Soc Pharm</source><year>2024</year><month>12</month><volume>16</volume><fpage>100510</fpage><comment>
<ext-link xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S2667-2766(24)00107-0" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1016/j.rcsop.2024.100510</pub-id><pub-id pub-id-type="medline">39399764</pub-id><pub-id pub-id-type="pii">S2667-2766(24)00107-0</pub-id><!--<pub-id pub-id-type="pmcid">PMC11470627</pub-id>--><pub-id pub-id-type="pmid">39399764</pub-id>
</element-citation></ref><ref id="ref126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kvarnstr&#x000f6;m</surname><given-names>K</given-names></name><name><surname>Westerholm</surname><given-names>A</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name><name><surname>Liira</surname><given-names>H</given-names></name></person-group><article-title>Factors contributing to medication adherence in patients with a chronic condition: a scoping review of qualitative research</article-title><source>Pharmaceutics</source><year>2021</year><month>07</month><day>20</day><volume>13</volume><issue>7</issue><fpage>1100</fpage><comment>
<ext-link xlink:href="https://www.mdpi.com/resolver?pii=pharmaceutics13071100" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.3390/pharmaceutics13071100</pub-id><pub-id pub-id-type="medline">34371791</pub-id><pub-id pub-id-type="pii">pharmaceutics13071100</pub-id><!--<pub-id pub-id-type="pmcid">PMC8309154</pub-id>--><pub-id pub-id-type="pmid">34371791</pub-id>
</element-citation></ref><ref id="ref127"><label>127</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><article-title>Medication without harm: WHO global patient safety challenge</article-title><year>2017</year><date-in-citation content-type="access-date">2024-05-23</date-in-citation><comment>
<ext-link xlink:href="https://iris.who.int/bitstream/handle/10665/255263/WHO-HIS-SDS-2017.6-eng.pdf;jsessionid=7101003388F62C8E9B433E7D11C77940?sequence=1" ext-link-type="uri">https://iris.who.int/bitstream/handle/10665/255263/WHO-HIS-SDS-2017.6-eng.pdf;jsessionid=7101003388F62C8E9B433E7D11C77940?sequence=1</ext-link>
</comment></element-citation></ref><ref id="ref128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammed</surname><given-names>MA</given-names></name><name><surname>Moles</surname><given-names>RJ</given-names></name><name><surname>Chen</surname><given-names>TF</given-names></name></person-group><article-title>Medication-related burden and patients' lived experience with medicine: a systematic review and metasynthesis of qualitative studies</article-title><source>BMJ Open</source><year>2016</year><month>02</month><day>02</day><volume>6</volume><issue>2</issue><fpage>e010035</fpage><comment>
<ext-link xlink:href="https://bmjopen.bmj.com/lookup/pmidlookup?view=long&#x00026;pmid=26839015" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1136/bmjopen-2015-010035</pub-id><pub-id pub-id-type="medline">26839015</pub-id><pub-id pub-id-type="pii">bmjopen-2015-010035</pub-id><!--<pub-id pub-id-type="pmcid">PMC4746464</pub-id>--></element-citation></ref><ref id="ref129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>SC</given-names></name><name><surname>Wallia</surname><given-names>A</given-names></name><name><surname>Wright</surname><given-names>S</given-names></name><name><surname>Wismer</surname><given-names>GA</given-names></name><name><surname>Infanzon</surname><given-names>AC</given-names></name><name><surname>Curtis</surname><given-names>LM</given-names></name><name><surname>Brokenshire</surname><given-names>SA</given-names></name><name><surname>Chung</surname><given-names>AE</given-names></name><name><surname>Reuland</surname><given-names>DS</given-names></name><name><surname>Hahr</surname><given-names>AJ</given-names></name><name><surname>Hornbuckle</surname><given-names>K</given-names></name><name><surname>Lockwood</surname><given-names>K</given-names></name><name><surname>Hall</surname><given-names>L</given-names></name><name><surname>Wolf</surname><given-names>MS</given-names></name></person-group><article-title>Electronic health record-based strategy to promote medication adherence among patients with diabetes: longitudinal observational study</article-title><source>J Med Internet Res</source><year>2019</year><month>10</month><day>21</day><volume>21</volume><issue>10</issue><fpage>e13499</fpage><comment>
<ext-link xlink:href="https://www.jmir.org/2019/10/e13499/" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.2196/13499</pub-id><pub-id pub-id-type="medline">31638592</pub-id><pub-id pub-id-type="pii">v21i10e13499</pub-id><!--<pub-id pub-id-type="pmcid">PMC6829279</pub-id>--><pub-id pub-id-type="pmid">31638592</pub-id>
</element-citation></ref><ref id="ref130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blecker</surname><given-names>S</given-names></name><name><surname>Schoenthaler</surname><given-names>A</given-names></name><name><surname>Martinez</surname><given-names>TR</given-names></name><name><surname>Belli</surname><given-names>HM</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Wong</surname><given-names>C</given-names></name><name><surname>Fitchett</surname><given-names>C</given-names></name><name><surname>Bearnot</surname><given-names>HR</given-names></name><name><surname>Mann</surname><given-names>D</given-names></name></person-group><article-title>Leveraging electronic health record technology and team care to address medication adherence: protocol for a cluster randomized controlled trial</article-title><source>JMIR Res Protoc</source><year>2023</year><month>07</month><day>07</day><volume>12</volume><fpage>e47930</fpage><comment>
<ext-link xlink:href="https://www.researchprotocols.org/2023//e47930/" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.2196/47930</pub-id><pub-id pub-id-type="medline">37418304</pub-id><pub-id pub-id-type="pii">v12i1e47930</pub-id><!--<pub-id pub-id-type="pmcid">PMC10362494</pub-id>--><pub-id pub-id-type="pmid">37418304</pub-id>
</element-citation></ref><ref id="ref131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beard</surname><given-names>L</given-names></name><name><surname>Schein</surname><given-names>R</given-names></name><name><surname>Morra</surname><given-names>D</given-names></name><name><surname>Wilson</surname><given-names>K</given-names></name><name><surname>Keelan</surname><given-names>J</given-names></name></person-group><article-title>The challenges in making electronic health records accessible to patients</article-title><source>J Am Med Inform Assoc</source><year>2012</year><month>01</month><day>01</day><volume>19</volume><issue>1</issue><fpage>116</fpage><lpage>20</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/22120207" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1136/amiajnl-2011-000261</pub-id><pub-id pub-id-type="medline">22120207</pub-id><pub-id pub-id-type="pii">amiajnl-2011-000261</pub-id><!--<pub-id pub-id-type="pmcid">PMC3240757</pub-id>--><pub-id pub-id-type="pmid">22120207</pub-id>
</element-citation></ref><ref id="ref132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis Giardina</surname><given-names>T</given-names></name><name><surname>Menon</surname><given-names>S</given-names></name><name><surname>Parrish</surname><given-names>DE</given-names></name><name><surname>Sittig</surname><given-names>DF</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name></person-group><article-title>Patient access to medical records and healthcare outcomes: a systematic review</article-title><source>J Am Med Inform Assoc</source><year>2014</year><volume>21</volume><issue>4</issue><fpage>737</fpage><lpage>41</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/24154835" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1136/amiajnl-2013-002239</pub-id><pub-id pub-id-type="medline">24154835</pub-id><pub-id pub-id-type="pii">amiajnl-2013-002239</pub-id><!--<pub-id pub-id-type="pmcid">PMC4078277</pub-id>--><pub-id pub-id-type="pmid">24154835</pub-id>
</element-citation></ref><ref id="ref133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lusignan</surname><given-names>S</given-names></name><name><surname>Mold</surname><given-names>F</given-names></name><name><surname>Sheikh</surname><given-names>A</given-names></name><name><surname>Majeed</surname><given-names>A</given-names></name><name><surname>Wyatt</surname><given-names>JC</given-names></name><name><surname>Quinn</surname><given-names>T</given-names></name><name><surname>Cavill</surname><given-names>M</given-names></name><name><surname>Gronlund</surname><given-names>TA</given-names></name><name><surname>Franco</surname><given-names>C</given-names></name><name><surname>Chauhan</surname><given-names>U</given-names></name><name><surname>Blakey</surname><given-names>H</given-names></name><name><surname>Kataria</surname><given-names>N</given-names></name><name><surname>Barker</surname><given-names>F</given-names></name><name><surname>Ellis</surname><given-names>B</given-names></name><name><surname>Koczan</surname><given-names>P</given-names></name><name><surname>Arvanitis</surname><given-names>TN</given-names></name><name><surname>McCarthy</surname><given-names>M</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Rafi</surname><given-names>I</given-names></name></person-group><article-title>Patients' online access to their electronic health records and linked online services: a systematic interpretative review</article-title><source>BMJ Open</source><year>2014</year><month>09</month><day>08</day><volume>4</volume><issue>9</issue><fpage>e006021</fpage><comment>
<ext-link xlink:href="https://bmjopen.bmj.com/lookup/pmidlookup?view=long&#x00026;pmid=25200561" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1136/bmjopen-2014-006021</pub-id><pub-id pub-id-type="medline">25200561</pub-id><pub-id pub-id-type="pii">bmjopen-2014-006021</pub-id><!--<pub-id pub-id-type="pmcid">PMC4158217</pub-id>--></element-citation></ref><ref id="ref134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mold</surname><given-names>F</given-names></name><name><surname>de Lusignan</surname><given-names>S</given-names></name><name><surname>Sheikh</surname><given-names>A</given-names></name><name><surname>Majeed</surname><given-names>A</given-names></name><name><surname>Wyatt</surname><given-names>JC</given-names></name><name><surname>Quinn</surname><given-names>T</given-names></name><name><surname>Cavill</surname><given-names>M</given-names></name><name><surname>Franco</surname><given-names>C</given-names></name><name><surname>Chauhan</surname><given-names>U</given-names></name><name><surname>Blakey</surname><given-names>H</given-names></name><name><surname>Kataria</surname><given-names>N</given-names></name><name><surname>Arvanitis</surname><given-names>TN</given-names></name><name><surname>Ellis</surname><given-names>B</given-names></name></person-group><article-title>Patients' online access to their electronic health records and linked online services: a systematic review in primary care</article-title><source>Br J Gen Pract</source><year>2015</year><month>03</month><volume>65</volume><issue>632</issue><fpage>e141</fpage><lpage>51</lpage><comment>
<ext-link xlink:href="https://bjgp.org/lookup/pmidlookup?view=long&#x00026;pmid=25733435" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.3399/bjgp15X683941</pub-id><pub-id pub-id-type="medline">25733435</pub-id><pub-id pub-id-type="pii">65/632/e141</pub-id><!--<pub-id pub-id-type="pmcid">PMC4337302</pub-id>--><pub-id pub-id-type="pmid">25733435</pub-id>
</element-citation></ref><ref id="ref135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Costa</surname><given-names>SN</given-names></name><name><surname>Kuhn</surname><given-names>IL</given-names></name><name><surname>Fritz</surname><given-names>Z</given-names></name></person-group><article-title>A systematic review of patient access to medical records in the acute setting: practicalities, perspectives and ethical consequences</article-title><source>BMC Med Ethics</source><year>2020</year><month>03</month><day>02</day><volume>21</volume><issue>1</issue><fpage>18</fpage><comment>
<ext-link xlink:href="https://bmcmedethics.biomedcentral.com/articles/10.1186/s12910-020-0459-6" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1186/s12910-020-0459-6</pub-id><pub-id pub-id-type="medline">32122332</pub-id><pub-id pub-id-type="pii">10.1186/s12910-020-0459-6</pub-id><!--<pub-id pub-id-type="pmcid">PMC7053049</pub-id>--><pub-id pub-id-type="pmid">32122332</pub-id>
</element-citation></ref><ref id="ref136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grossman</surname><given-names>LV</given-names></name><name><surname>Choi</surname><given-names>SW</given-names></name><name><surname>Collins</surname><given-names>S</given-names></name><name><surname>Dykes</surname><given-names>PC</given-names></name><name><surname>O'Leary</surname><given-names>KJ</given-names></name><name><surname>Rizer</surname><given-names>M</given-names></name><name><surname>Strong</surname><given-names>P</given-names></name><name><surname>Yen</surname><given-names>PY</given-names></name><name><surname>Vawdrey</surname><given-names>DK</given-names></name></person-group><article-title>Implementation of acute care patient portals: recommendations on utility and use from six early adopters</article-title><source>J Am Med Inform Assoc</source><year>2018</year><month>04</month><day>01</day><volume>25</volume><issue>4</issue><fpage>370</fpage><lpage>9</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/29040634" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1093/jamia/ocx074</pub-id><pub-id pub-id-type="medline">29040634</pub-id><pub-id pub-id-type="pii">4103502</pub-id><!--<pub-id pub-id-type="pmcid">PMC7646852</pub-id>--><pub-id pub-id-type="pmid">29040634</pub-id>
</element-citation></ref><ref id="ref137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammer</surname><given-names>A</given-names></name><name><surname>Wagner</surname><given-names>A</given-names></name><name><surname>Rieger</surname><given-names>MA</given-names></name><name><surname>Manser</surname><given-names>T</given-names></name><collab>WorkSafeMed Project Consortium#</collab></person-group><article-title>Assessing the quality of medication documentation: development and feasibility of the MediDocQ instrument for retrospective chart review in the hospital setting</article-title><source>BMJ Open</source><year>2019</year><month>11</month><day>18</day><volume>9</volume><issue>11</issue><fpage>e034609</fpage><comment>
<ext-link xlink:href="https://bmjopen.bmj.com/lookup/pmidlookup?view=long&#x00026;pmid=31740477" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1136/bmjopen-2019-034609</pub-id><pub-id pub-id-type="medline">31740477</pub-id><pub-id pub-id-type="pii">bmjopen-2019-034609</pub-id><!--<pub-id pub-id-type="pmcid">PMC6886911</pub-id>--></element-citation></ref><ref id="ref138"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armistead</surname><given-names>LT</given-names></name><name><surname>Cruz</surname><given-names>A</given-names></name><name><surname>Levitt</surname><given-names>JM</given-names></name><name><surname>McClurg</surname><given-names>MR</given-names></name><name><surname>Blanchard</surname><given-names>CM</given-names></name></person-group><article-title>Medication therapy problem documentation and reporting: a review of the literature and recommendations</article-title><source>J Am Coll Clin Pharm</source><year>2021</year><month>07</month><day>30</day><volume>4</volume><issue>10</issue><fpage>1337</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1002/jac5.1502</pub-id></element-citation></ref><ref id="ref139"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Diery</surname><given-names>T</given-names></name><name><surname>Freeman</surname><given-names>H</given-names></name><name><surname>Page</surname><given-names>AT</given-names></name><name><surname>Cross</surname><given-names>AJ</given-names></name><name><surname>Hawthorne</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name></person-group><article-title>What types of information do pharmacists include in comprehensive medication management review reports? A qualitative content analysis</article-title><source>Int J Clin Pharm</source><year>2023</year><month>06</month><day>17</day><volume>45</volume><issue>3</issue><fpage>712</fpage><lpage>21</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/36932315" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1007/s11096-023-01561-5</pub-id><pub-id pub-id-type="medline">36932315</pub-id><pub-id pub-id-type="pii">10.1007/s11096-023-01561-5</pub-id><!--<pub-id pub-id-type="pmcid">PMC10250515</pub-id>--><pub-id pub-id-type="pmid">36932315</pub-id>
</element-citation></ref><ref id="ref140"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>RA</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Chan</surname><given-names>V</given-names></name><name><surname>Richardson</surname><given-names>B</given-names></name><name><surname>Tanner</surname><given-names>F</given-names></name><name><surname>Dorevitch</surname><given-names>MI</given-names></name></person-group><article-title>Pharmacist-physician collaboration to improve the accuracy of medication information in electronic medical discharge summaries: effectiveness and sustainability</article-title><source>Pharmacy (Basel)</source><year>2019</year><month>12</month><day>30</day><volume>8</volume><issue>1</issue><fpage>2</fpage><comment>
<ext-link xlink:href="https://www.mdpi.com/resolver?pii=pharmacy8010002" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.3390/pharmacy8010002</pub-id><pub-id pub-id-type="medline">31905902</pub-id><pub-id pub-id-type="pii">pharmacy8010002</pub-id><!--<pub-id pub-id-type="pmcid">PMC7151653</pub-id>--><pub-id pub-id-type="pmid">31905902</pub-id>
</element-citation></ref><ref id="ref141"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craske</surname><given-names>ME</given-names></name><name><surname>Hardeman</surname><given-names>W</given-names></name><name><surname>Steel</surname><given-names>N</given-names></name><name><surname>Twigg</surname><given-names>MJ</given-names></name></person-group><article-title>Components of pharmacist-led medication reviews and their relationship to outcomes: a systematic review and narrative synthesis</article-title><source>BMJ Qual Saf</source><year>2024</year><month>11</month><day>20</day><volume>33</volume><issue>12</issue><fpage>808</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1136/bmjqs-2024-017283</pub-id><pub-id pub-id-type="medline">39013596</pub-id><pub-id pub-id-type="pii">bmjqs-2024-017283</pub-id></element-citation></ref><ref id="ref142"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husband</surname><given-names>A</given-names></name><name><surname>Robinson-Barella</surname><given-names>A</given-names></name></person-group><article-title>Integration and connection: the key to effectiveness of large-scale pharmacist-led medication reviews?</article-title><source>BMJ Qual Saf</source><year>2024</year><month>11</month><day>20</day><volume>33</volume><issue>12</issue><fpage>765</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1136/bmjqs-2024-017740</pub-id><pub-id pub-id-type="medline">39214679</pub-id><pub-id pub-id-type="pii">bmjqs-2024-017740</pub-id></element-citation></ref><ref id="ref143"><label>143</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Saranto</surname><given-names>K</given-names></name><name><surname>Kinnunen</surname><given-names>UM</given-names></name><name><surname>Liljamo</surname><given-names>P</given-names></name><name><surname>Mykk&#x000e4;nen</surname><given-names>M</given-names></name><name><surname>Kuusisto</surname><given-names>A</given-names></name><name><surname>Kivek&#x000e4;s</surname><given-names>E</given-names></name></person-group><person-group person-group-type="editor"><name><surname>H&#x000fc;bner</surname><given-names>UH</given-names></name><name><surname>Mustata Wilson</surname><given-names>G</given-names></name><name><surname>Morawski</surname><given-names>TS</given-names></name><name><surname>Ball</surname><given-names>MJ</given-names></name></person-group><article-title>Interprofessional structured data: supporting the primary and secondary use of patient documentation</article-title><source>Nursing Informatics</source><year>2022</year><publisher-loc>Cham, Switzerland</publisher-loc><publisher-name>Springer</publisher-name></element-citation></ref><ref id="ref144"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toivo</surname><given-names>T</given-names></name><name><surname>Dimitrow</surname><given-names>M</given-names></name><name><surname>Puustinen</surname><given-names>J</given-names></name><name><surname>Savela</surname><given-names>E</given-names></name><name><surname>Pelkonen</surname><given-names>K</given-names></name><name><surname>Kiuru</surname><given-names>V</given-names></name><name><surname>Suominen</surname><given-names>T</given-names></name><name><surname>Kinnunen</surname><given-names>S</given-names></name><name><surname>Uunim&#x000e4;ki</surname><given-names>M</given-names></name><name><surname>Kivel&#x000e4;</surname><given-names>SL</given-names></name><name><surname>Leikola</surname><given-names>S</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name></person-group><article-title>Coordinating resources for prospective medication risk management of older home care clients in primary care: procedure development and RCT study design for demonstrating its effectiveness</article-title><source>BMC Geriatr</source><year>2018</year><month>03</month><day>16</day><volume>18</volume><issue>1</issue><fpage>74</fpage><comment>
<ext-link xlink:href="https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-018-0737-z" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1186/s12877-018-0737-z</pub-id><pub-id pub-id-type="medline">29548304</pub-id><pub-id pub-id-type="pii">10.1186/s12877-018-0737-z</pub-id><!--<pub-id pub-id-type="pmcid">PMC5857129</pub-id>--><pub-id pub-id-type="pmid">29548304</pub-id>
</element-citation></ref><ref id="ref145"><label>145</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Toivo</surname><given-names>T</given-names></name></person-group><source>Prospective medication risk management in primary care: enhancing coordination of care and community pharmacists' participation. Dissertation</source><year>2020</year><date-in-citation content-type="access-date">2024-11-02</date-in-citation><publisher-name>University of Helsinki</publisher-name><comment>
<ext-link xlink:href="https://helda.helsinki.fi/items/c4551dee-6d6e-4a72-9c8e-aacf23fa5515" ext-link-type="uri">https://helda.helsinki.fi/items/c4551dee-6d6e-4a72-9c8e-aacf23fa5515</ext-link>
</comment></element-citation></ref><ref id="ref146"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>SB</given-names></name><name><surname>Bakken</surname><given-names>S</given-names></name><name><surname>Dine</surname><given-names>D</given-names></name><name><surname>Hyun</surname><given-names>S</given-names></name><name><surname>Mendonca</surname><given-names>E</given-names></name><name><surname>Morrison</surname><given-names>F</given-names></name><name><surname>Bright</surname><given-names>T</given-names></name><name><surname>Van Vleck</surname><given-names>T</given-names></name><name><surname>Wrenn</surname><given-names>J</given-names></name><name><surname>Stetson</surname><given-names>P</given-names></name></person-group><article-title>An electronic health record based on structured narrative</article-title><source>J Am Med Inform Assoc</source><year>2008</year><month>01</month><day>01</day><volume>15</volume><issue>1</issue><fpage>54</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1197/jamia.m2131</pub-id><pub-id pub-id-type="pmid">17947628</pub-id>
</element-citation></ref><ref id="ref147"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tayefi</surname><given-names>M</given-names></name><name><surname>Ngo</surname><given-names>P</given-names></name><name><surname>Chomutare</surname><given-names>T</given-names></name><name><surname>Dalianis</surname><given-names>H</given-names></name><name><surname>Salvi</surname><given-names>E</given-names></name><name><surname>Budrionis</surname><given-names>A</given-names></name><name><surname>Godtliebsen</surname><given-names>F</given-names></name></person-group><article-title>Challenges and opportunities beyond structured data in analysis of electronic health records</article-title><source>WIREs Comput Stat</source><year>2021</year><month>02</month><day>14</day><volume>13</volume><issue>6</issue><fpage>13</fpage><comment>
<ext-link xlink:href="https://doi.org/10.1002/wics.1549" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1002/wics.1549</pub-id></element-citation></ref><ref id="ref148"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lusignan</surname><given-names>S</given-names></name><name><surname>Wells</surname><given-names>SE</given-names></name><name><surname>Hague</surname><given-names>NJ</given-names></name><name><surname>Thiru</surname><given-names>K</given-names></name></person-group><article-title>Managers see the problems associated with coding clinical data as a technical issue whilst clinicians also see cultural barriers</article-title><source>Methods Inf Med</source><year>2018</year><month>02</month><day>08</day><volume>42</volume><issue>04</issue><fpage>416</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1055/s-0038-1634239</pub-id></element-citation></ref><ref id="ref149"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebbers</surname><given-names>T</given-names></name><name><surname>Kool</surname><given-names>RB</given-names></name><name><surname>Smeele</surname><given-names>LE</given-names></name><name><surname>Dirven</surname><given-names>R</given-names></name><name><surname>den Besten</surname><given-names>CA</given-names></name><name><surname>Karssemakers</surname><given-names>LH</given-names></name><name><surname>Verhoeven</surname><given-names>T</given-names></name><name><surname>Herruer</surname><given-names>JM</given-names></name><name><surname>van den Broek</surname><given-names>GB</given-names></name><name><surname>Takes</surname><given-names>RP</given-names></name></person-group><article-title>The impact of structured and standardized documentation on documentation quality; a multicenter, retrospective study</article-title><source>J Med Syst</source><year>2022</year><month>05</month><day>27</day><volume>46</volume><issue>7</issue><fpage>46</fpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/35618978" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1007/s10916-022-01837-9</pub-id><pub-id pub-id-type="medline">35618978</pub-id><pub-id pub-id-type="pii">10.1007/s10916-022-01837-9</pub-id><!--<pub-id pub-id-type="pmcid">PMC9135789</pub-id>--><pub-id pub-id-type="pmid">35618978</pub-id>
</element-citation></ref><ref id="ref150"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazi</surname><given-names>S</given-names></name><name><surname>Handley</surname><given-names>JL</given-names></name><name><surname>Milicia</surname><given-names>AP</given-names></name><name><surname>Ratwani</surname><given-names>RM</given-names></name><name><surname>Adams</surname><given-names>KT</given-names></name><name><surname>Jones</surname><given-names>R</given-names></name><name><surname>Krevat</surname><given-names>S</given-names></name></person-group><article-title>Free text as part of electronic health record orders: context or concern?</article-title><source>Patient Safety</source><year>2024</year><volume>6</volume><issue>1</issue><pub-id pub-id-type="doi">10.33940/001c.118587</pub-id></element-citation></ref><ref id="ref151"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skentzos</surname><given-names>S</given-names></name><name><surname>Shubina</surname><given-names>M</given-names></name><name><surname>Plutzky</surname><given-names>J</given-names></name><name><surname>Turchin</surname><given-names>A</given-names></name></person-group><article-title>Structured vs. unstructured: factors affecting adverse drug reaction documentation in an EMR repository</article-title><source>AMIA Annu Symp Proc</source><year>2011</year><volume>2011</volume><fpage>1270</fpage><lpage>9</lpage><comment>
<ext-link xlink:href="https://europepmc.org/abstract/MED/22195188" ext-link-type="uri"/>
</comment><pub-id pub-id-type="medline">22195188</pub-id><!--<pub-id pub-id-type="pmcid">PMC3243255</pub-id>--><pub-id pub-id-type="pmid">22195188</pub-id>
</element-citation></ref><ref id="ref152"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebbers</surname><given-names>T</given-names></name><name><surname>Takes</surname><given-names>RP</given-names></name><name><surname>Smeele</surname><given-names>LE</given-names></name><name><surname>Kool</surname><given-names>RB</given-names></name><name><surname>van den Broek</surname><given-names>GB</given-names></name><name><surname>Dirven</surname><given-names>R</given-names></name></person-group><article-title>The implementation of a multidisciplinary, electronic health record embedded care pathway to improve structured data recording and decrease electronic health record burden</article-title><source>Int J Med Inform</source><year>2024</year><month>04</month><volume>184</volume><fpage>105344</fpage><comment>
<ext-link xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S1386-5056(24)00007-8" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1016/j.ijmedinf.2024.105344</pub-id><pub-id pub-id-type="medline">38310755</pub-id><pub-id pub-id-type="pii">S1386-5056(24)00007-8</pub-id><pub-id pub-id-type="pmid">38310755</pub-id>
</element-citation></ref><ref id="ref153"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cahill</surname><given-names>M</given-names></name><name><surname>Cleary</surname><given-names>BJ</given-names></name><name><surname>Cullinan</surname><given-names>S</given-names></name></person-group><article-title>The influence of electronic health record design on usability and medication safety: systematic review</article-title><source>BMC Health Serv Res</source><year>2025</year><month>01</month><day>06</day><volume>25</volume><issue>1</issue><fpage>31</fpage><comment>
<ext-link xlink:href="https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-024-12060-2" ext-link-type="uri"/>
</comment><pub-id pub-id-type="doi">10.1186/s12913-024-12060-2</pub-id><pub-id pub-id-type="medline">39762805</pub-id><pub-id pub-id-type="pii">10.1186/s12913-024-12060-2</pub-id><!--<pub-id pub-id-type="pmcid">PMC11705737</pub-id>--><pub-id pub-id-type="pmid">39762805</pub-id>
</element-citation></ref><ref id="ref154"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khosravi</surname><given-names>B</given-names></name><name><surname>Rouzrokh</surname><given-names>P</given-names></name><name><surname>Erickson</surname><given-names>BJ</given-names></name></person-group><article-title>Getting more out of large databases and EHRs with natural language processing and artificial intelligence: the future is here</article-title><source>J Bone Joint Surg Am</source><year>2022</year><month>10</month><day>19</day><volume>104</volume><issue>Suppl 3</issue><fpage>51</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.2106/JBJS.22.00567</pub-id><pub-id pub-id-type="medline">36260045</pub-id><pub-id pub-id-type="pii">00004623-202210191-00012</pub-id><pub-id pub-id-type="pmid">36260045</pub-id>
</element-citation></ref><ref id="ref155"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falcetta</surname><given-names>FS</given-names></name><name><surname>de Almeida</surname><given-names>FK</given-names></name><name><surname>Lemos</surname><given-names>JC</given-names></name><name><surname>Goldim</surname><given-names>JR</given-names></name><name><surname>da Costa</surname><given-names>CA</given-names></name></person-group><article-title>Automatic documentation of professional health interactions: a systematic review</article-title><source>Artif Intell Med</source><year>2023</year><month>03</month><volume>137</volume><fpage>102487</fpage><pub-id pub-id-type="doi">10.1016/j.artmed.2023.102487</pub-id><pub-id pub-id-type="medline">36868684</pub-id><pub-id pub-id-type="pii">S0933-3657(23)00001-5</pub-id><pub-id pub-id-type="pmid">36868684</pub-id>
</element-citation></ref></ref-list></back></article>